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ABSTRACT 
KAREN ANN CHERKIS: Structural Analyses of AvrRpm1 and HopBA1: Two TTSS 
Effectors from the Plant Phytopathogen Pseudomonas syringae. 
(Under the direction of Jeffery L. Dangl, PhD and John Sondek, PhD) 
 
Plants recognize microbes via specific pattern recognition receptors that are 
activated by microbe-associated molecular patterns (MAMPs), resulting in MAMP-
triggered immunity (MTI). Successful pathogens bypass MTI in genetically diverse 
hosts via deployment of effectors (virulence factors) that inhibit MTI responses, 
leading to pathogen proliferation. Plant pathogenic bacteria like Pseudomonas 
syringae utilize a type III secretion system to deliver effectors into cells. These 
effectors can contribute to pathogen virulence or elicit disease resistance, depending 
upon the host plant genotype. In disease resistant genotypes, intracellular immune 
receptors, typically belonging to the nucleotide binding leucine-rich repeat family of 
proteins, perceive bacterial effector(s) and initiate downstream defense responses 
(effector triggered immunity) that include the hypersensitive response, and 
transcriptional re-programming leading to various cellular outputs that collectively 
halt pathogen growth. Nucleotide binding leucine-rich repeat sensors can be 
indirectly activated via perturbation of a host protein acting as an effector target. 
AvrRpm1 and HopBa1 are two P. syringae type III effectors. Upon secretion into the 
 iii 
host cell, AvrRpm1 is directed to the plasma membrane, where it contributes to 
virulence. This is correlated with phosphorylation of Arabidopsis RIN4 in vivo. The 
RPM1 nucleotide binding leucine-rich repeat sensor perceives RIN4 perturbation in 
disease resistant plants, leading to a successful immune response. Here, we 
demonstrate that AvrRpm1 has a fold homologous to the catalytic domain of 
poly(ADP-ribosyl)polymerase. Site-directed mutagenesis of each residue in the 
putative catalytic triad, His63-Tyr122-Asp185 of AvrRpm1 results in loss of both 
AvrRpm1- dependent virulence and AvrRpm1-mediated activation of RPM1, but, 
surprisingly, causes a gain of function: the ability to activate the RPS2 nucleotide 
binding leucine-rich repeat sensor.  Additionally, we determined the crystal structure 
of HopBA1. We were able to show that despite low sequence similarity, HopBA1 
shares structural homology to the ChaN/ EreA-like superfamily of proteins.  Through 
structural analysis of HopBA1 we generated several missense mutations that are 
critical for recognition inside the host.  We were also able to putatively classify two 
additional type III effectors, HopB1 and HopAC1, from P. syringae as additional 
ChaN/EreA-like superfamily members. 
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CHAPTER ONE 
INTRODUCTION 
Preface 
Understanding the molecular mechanisms by which pathogens are able to 
evade the immune system of their host is an area of research undergoing significant 
growth.  Type three secretion system (TTSS) effectors, which are the focus of this 
dissertation, are used by pathogens to bypass the host immune system by various 
and often unknown mechanisms.  The advent of high-throughput sequencing 
initiatives coupled with promoter motif searches have enabled the identification in 
the Pseudomonas syringae genome of multiple families of TTSS effectors. Despite 
these technological advances, we lack the ability to accurately assign enzymatic 
functions to these proteins. Complicating these studies, TTSS effectors show very 
little overall sequence identity with proteins of known function, making attempts at 
classification through sequence similarity contra spem spero, hope against hope.  
Instead, we rely on characterization of disease outputs once these TTSS effectors 
are inside the host. However, disease outputs are not direct read-outs for enzymatic 
mechanisms of TTSS effectors.  Accepting the unique challenges of studying TTSS 
effectors, there is a significant drive toward structural-based initiatives to 
characterize the effectors.  In this research, we applied a structural-based approach 
characterized by identification of effector folds allowing for effector protein family 
classification, functionality determination, and elucidation of binding partners.  We 
 2 
complete our analysis by tying these structural initiatives to two different, biologically 
relevant contexts, resulting in an increased understanding of the mechanisms 
employed by these two TTSS effectors. This will be discussed in the following 
chapters. 
 
Pseudomonas syringae 
 Pseudomonas syringae is a model pathogenic tool for studying host-pathogen 
interaction because of the current efforts in sequencing the genomes of the different 
pathovars and for its ability to infect the model plant Arabidopsis thaliana. In 
addition, the genomes of different accessions (inbreds) of Arabidopsis thaliana that 
show varying disease resistance phenotypes to Pseudomonas syringae infection are 
currently being sequenced [9]. Pseudomonas syringae is a Gram-negative 
phytopathogen.  Typically it lives first as an epiphyte on the surface of the host plant 
and then switches to invade and colonize the apoplastic space [10].  Pseudomonas 
syringae is responsible for significant amounts of crop damage every year making it 
a critical phytopathogen to target for research.  Each pathovar or race of 
Pseudomonas syringae exhibits a high degree of host specificity infecting only a few 
host species or only a few cultivars within a species [9,10]. This altered specificity is 
due in large part to the TTSS and the varied repertoire of effectors the bacterium 
releases into the host.  
 
 
 
 3 
Plant Innate Immunity 
When observing host-pathogen dynamics, the first process to ward off 
infection begins with the innate immune response.  Plant innate immunity is 
triggered upon recognition of molecules associated with pathogens [11].  These 
molecules, known as microbe associated molecular patterns (MAMPs), are 
evolutionarily conserved and slow to evolve [12,13].  MAMPs include the 22 residue 
flagellar peptide flg22 and the 18 residue acetylated peptide from EF-TU, elongation 
factor elf18, both conserved in bacterial pathogens including P. syringae [14,15].  
Recognition on Arabidopsis thaliana occurs through surface exposed pattern 
recognition receptors (PRR)/ receptor like kinases (RLK), such as the recognition of 
flg22 or elf18 by the transmembrane host receptors FLS-2 and EFR respectively 
[16,17].  This recognition leads to early defense responses, such as transcriptional 
reprogramming of defense genes like Pathogenesis Related 1 (PR1) and activation 
of the kinase signaling cascade (MKK4/MKK5 and MPK3/MPK6 for flg22/FLS2) 
[14,16,18,19]. Later responses include callose deposition, a thickening of the cell 
wall that serves as a physical barrier between uninfected cells and the site of 
infection [14].  The sum of these responses is known as MAMP triggered immunity 
(MTI), and it is initiated to inhibit pathogen growth, colonization and disease 
occurrence once initial contact has been made (Figure 1.1A) [12]. 
 
Type Three Secretion System and Effectors 
P. syringae has acquired a TTSS system for subverting the host innate 
immune response.  The TTSS was first identified in Yersinia pestis, but it is a shared 
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mechanism for delivery of virulence proteins among many Gram-negative 
pathogenic bacteria, including Salmonella typhimurium, Shigella flexneri, 
Pseudomonas aeruginosa, and Pseudomonas syringae [20,21].  The TTSS 
apparatus is responsible for piercing the host cell membrane and injecting the 
effectors into the host (Figure 1.1B) [20,22]. The TTSS in P. syringae and other 
Gram-negative plant pathogenic bacteria is encoded by the hypersensitive reaction 
and pathogenicity (hrp) genes, which are induced when the Pseudomonad enters 
the apoplastic space [23,24]. These genes encode the TTSS apparatus; effectors 
can be linked to the hrp cluster, encoded elsewhere on the chromosome, or found 
on plasmids [20,24].  The TTSS apparatus genes are quite conserved while the 
effector genes are generally more divergent [20,24].  
 A single pathovar of Pseudomonas syringae is capable of simultaneously 
delivering 15-30 different effectors into the host cell although a total of ~50 different 
effector families have been identified across all pathovars [10,25].  Delivery of these 
effectors through the TTSS apparatus is dependent upon the N-terminal 15 amino 
acids. Some effectors carry targeting sequences and rely on host post-translational 
modifications for proper localization and function once inside the host [6,26].  Other 
TTSS effectors require additional modification, for example, the TTSS effector 
protein AvrRps4 is cleaved from a 32.5 kDa protein into a shorter 11kDa protein 
once inside the host, and this shorter protein carries the virulence function [26].   
Once inside the host, bacterial growth is due to the virulence factors encoded 
by a given P. syringae strain; this is thought to be accomplished through two 
mechanisms: a) manipulation of host targets that allows for release of H2O or 
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nutrients from the cellular compartments into the apoplastic space and b) 
manipulation of host targets that allows the bacterium to elude MTI (Figure 1.1C left 
side) [10]. A specific mutant, P. syringae pv. tomato DC3000hrcC is deficient in the 
ability to secrete TTSS effectors (via mutation to the TTSS apparatus) and cannot 
overcome MTI to promote bacterial growth [27]. The repertoire of the effectors 
delivered into the host cells is thought to include redundant functions and, to the 
extent that some effectors can block the perception of other effectors, antagonistic 
functions [10]. Thus, loss of any single effector often does not result in loss of 
virulence [10]. Rather, it can manifest as only an attenuation of symptoms within the 
host [10,28].  Additionally, it is also important to consider that acquiring multiple 
effectors could be a means of increasing host range specificity rather than a need for 
overlapping function [28].   
 
Disease Resistance Proteins 
In an effort to combat the manipulation of host targets by TTSS effectors, 
plants have evolved disease resistance proteins (R proteins) [27].  R proteins are 
responsible for both recognition of the manipulation on host cellular targets by TTSS 
effectors, and initiation of downstream defense responses (Figure 1C right side) 
[27,29].  R proteins can monitor the targets of effectors rather than the effectors 
themselves and as such are capable of monitoring more than one effector [12]. A 
caveat to this is the direct recognition of the effectors AvrPto and AvrPtoB by the R 
protein Pto that is further facilitated by an additional R protein Prf, whose structural 
interactions will be discussed in greater detail later [30].  When an R protein 
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recognizes effector function, a defense response called effector triggered immunity 
(ETI) is mounted [12].  R proteins determine the resistance portfolio of the plant in 
that not all accessions have the same complement of available R proteins that will 
enable them to equally recognize the population of effectors [27].  When an effector 
goes unrecognized by the host, the host is said to be disease susceptible; when an 
effector is recognized the host is disease resistant.  Activation of R proteins leads to 
an influx of calcium ions, an extracellular oxidative burst, altered transcriptional 
profiles, and localized cell death around the site of infection known as the 
hypersensitive response (HR) [27,31].  ETI responses are quicker and quantitatively 
stronger than MTI responses. These cumulative observations further the need to 
study individual TTSS effectors, their targets and the R proteins involved in 
recognition, in a structural context away from the ambiguous and often redundant 
phenotypes observed in plants. 
 
Advances in Identification of Protein Folds 
Proteins take on dynamic, three dimensional conformations allowing for 
unique and tunable interactions with other cellular components, including small 
molecules, nucleic acids, and other proteins.  These interactions are the platform for 
essential cellular processes.  Disruption and reorganization of these interactions by 
TTSS effectors is a critical means to manipulate host targets, promote virulence of 
the pathogen and evade detection by the host [32].  In an effort to characterize how 
these disruptions occur, protein structure can be evaluated by experimentally 
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determining it with either X-ray crystallography or nuclear magnetic resonance 
(NMR) or by estimating it with computational homology modeling. 
X-ray crystallography and NMR are the only two spectroscopic techniques 
capable of producing high resolution, multidimensional coordinates of proteins.  
Other techniques are limited in that they can only provide auxiliary information and 
are frequently dependent on these coordinates for interpretation [33]. 
Aiding overall structural characterization of proteins is the growth of publicly 
available structural data found in resources like the protein data bank (PDB).  
Additionally, there have been vast improvements made to computational analyses 
used to derive structural information from experimental data [34], the emergence of 
synchrotron sources for radiation [35], incorporation of anomalous signals into the 
peptide chain [36], and the efforts of structural genomics consortia (SGC).  These 
advances are not without caveats. For example, not every structure deposited has 
an annotated function.  It is estimated that nearly 30-50% of all deposited structures 
from SGC lack a functional annotation [35].  While contributions of the SGC cannot 
be diminished, it is interesting to note that papers linking structural biology to a 
functional output are cited with much greater frequency [35].   
To overcome this barrier of ‘folds without function and function without folds’, 
computational approaches are being used.  These computational approaches 
include structure alignment, identification of homologous folds and homology 
modeling, and functional analysis based on tertiary structure.  The computational 
approach can give “strong” functional clues when sequence similarity is greater than 
30% [35].  For sequences with less than 30% similarity, determining shared or 
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homologous folds allows for the investigation of divergent evolutionary relationships 
and the possibility of a shared ancestral function.  Additionally, the presence of 
common motifs, ligand binding sites, and interaction platforms across dissimilar folds 
can also aid in functional characterization [35].  Concomitant with computational 
approaches to predict protein structure are computational approaches that use 
structural data such as quantum mechanical dynamics for enzyme reactions, 
molecular dynamics for membrane protein structures, and simulated docking, which 
can be used to interrogate protein-protein and protein-ligand interactions.  In the 
end, all of these computational techniques must be experimentally validated by 
traditional biochemical, genetic, and proteomic methods in order to properly assess 
their accuracy. 
Simply stated, homology modeling involves taking the sequence of a protein 
for which the structure is unknown and calculating an estimated structure using a 
known and homologous structure as a template. The first homology models were 
created in the late 1970s [33].  The steps for generating a comparative model are as 
follows: finding a suitable template protein or proteins for the target, aligning the 
target to the template protein(s), identifying structurally conserved and predicting 
structurally variable regions, modeling the side chains, and evaluating the model 
[37].  The models built today with a fully automated web server are continually 
increasing their accuracy [33].  There are three commonly used methods for 
generating homology models: rigid-body assembly, modeling by segment matching, 
and modeling by satisfaction of spatial restraints.  Rigid-body assembly was the first 
method developed and is still the most common method used to model protein 
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structure.  In rigid body assembly, conserved structural elements (rigid bodies) from 
homologous proteins are used to generate a map of secondary structure [37,38].  
This two dimensional map of rigid bodies is then fit onto a template structure.  The 
second approach, modeling by segment matching uses a database of short 
structural elements, energy, and/or geometry rules and then approximates the 
position of conserved residues from templates.  Lastly, modeling by satisfaction of 
spatial restraints, uses distance geometries or optimization techniques to satisfy 
spatial restraints obtained from the alignment of the target sequence to the known 
structure [38]. Errors in comparative modeling come in different types: distortions in 
correctly aligned regions, distortions in insertions, and distortions in incorrectly 
aligned regions [38]. Evaluation can typically identify the inaccurately modeled 
regions and because of this using a model is still generally better than using only the 
homologous template structure when trying to characterize a protein [38].  Explicit 
modeling of variable regions or regions that may contain differences between 
homologous folds allows for identification of novel functionality or regions of 
specificity [37].  Homology modeling gives a researcher great power when 
investigating protein structure.  In 1997, approximately one third of the known protein 
sequences were related to at least one of the known protein structures; suggesting 
that at that time the number of sequences that could be accurately modeled was an 
order of magnitude larger than the number of experimentally determined protein 
structures [38].  Additionally, according to statistics available on the PDB website, 
the average number of new folds reported annually hovered around 100 in 1997.  
Since 2006 this has dramatically dropped to 0 new folds reported after 2008 (6 
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folds).  This drop in new folds has occurred even though there was continuous 
growth in the number of new structures reported with 8,093 in 2011. 
 
The Strucutral Biology of TTSS Effectors and the Functional Insights Provided 
 We analyzed the interactions of three sets of TTSS effectors whose 
structures had been previously determined as examples of how structural biology 
and homology could inform functional studies. These examples serve as a prelude 
to the experimental work described in subsequent chapters.  Additionally these 
examples highlight both the achievements and inherent complications of TTSS 
effector driven structural biology. 
 
AvrPto / AvrPtoB and their Kinase Host Targets: Decoys and Virulence Targets 
P. syringae pv. tomato includes two effector proteins in its repertoire AvrPto 
and AvrPtoB that directly interact with the Pto kinase R protein, and is perceived by 
an additional nucleotide-binding leucine-rich repeat R protein Prf, resulting in ETI 
[39].  The necessity for Prf activity in ETI, coupled with the lack of a role for Pto in 
MTI, gave rise to the hypothesis that Pto may function as a molecular decoy for the 
virulence functions for both AvrPto and AvrPtoB [39,40].  The determination of the 
complex structures of AvrPto/Pto, AvrPtoB/Pto, and AvrPtoB/BAK1 provide insights 
into a common mechanism for interaction with host immune kinase domains [41-44].  
AvrPto is a single domain protein whereas AvrPtoB contains an N- and a C-terminal 
domain, with the N-terminal domain binding to both Pto and BAK1 [41,43].  
Comparative analysis of the interaction interfaces between AvrPto and AvrPtoB with 
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Pto reveal both common and divergent structural contacts. The first interaction 
interface of AvrPto with Pto occurs when the partially hydrophobic GINP loop of 
AvrPto interacts with the P+1 loop of Pto (Figure 1.2), and the second being when 
the end of the helical bundle of AvrPto interacts with the loop immediately preceding 
the first β sheet of Pto (Figure 1.3).  Owing to the fact that these interactions occur 
on fringe regions of AvrPto, this protein remains largely unchanged when complexed 
with Pto, except the GINP motif that undergoes a local change to a more ordered 
state [44]. Hydrogen bonding between the main chains of the two proteins, and 
hydrophobic packing of I96 from AvrPto into a hydrophobic pocket of Pto dictates the 
interactions in the first interface (Figure 1.2).  Interestingly, the N-terminal domain of 
AvrPtoB is capable of interacting with both Pto and BAK1, an RLK showing 
homology with Pto in its kinase domain, while the C-terminal domain of AvrPtoB is 
an E-3 ubiquitin ligase [42,45].  The N-terminal domain can be subdivided into two 
helical bundles, the first (117-206) is an interaction platform for Pto and the second 
(250-359) is an interaction platform for BAK1 [41,42].  These two kinase interacting 
domains share only 20% sequence identity but are believed to have arisen from a 
duplication event [41].  The interaction between AvrPtoB and Pto occurs at two 
interfaces, the first being the analogous region to the GINP motif (VAFS in AvrPtoB), 
where again the primary interaction is hydrogen bonding that occurs between the 
hydrophobic V159 of AvrPtoB and G203 of Pto (P+1 Loop) (Figure 1.2 and 1.3) [42].  
The second site of interaction is composed of extensive hydrophobic interactions 
(Figure 1.3) [42].  The interaction between BAK1 and AvrPtoB is unique in that there 
are three interaction surfaces as opposed to two interaction surfaces seen with 
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AvrPtoB and Pto  (Figure 1.3) [41,42].  Also, the orientation of the individual helical 
bundles of AvrPtoB must switch (180° rotation) in order for the appropriate 
interaction to occur.  Again, the first interaction surface is between the hydrophobic 
L336 in AvrPtoB and G454 in BAK1 (P+1 loop) (Figure 1.2) [41].  The second 
interface is dominated by interactions formed between R271 of AvrPtoB and 
residues in BAK1 while the third interface consists of primarily hydrophobic 
interactions of AvrPtoB with α2 and α3 of BAK1 [41]. 
  An additional requirement for interaction between Pto and the effectors 
AvrPto and AvrPtoB is the phosphorylation of Pto at T199, confirmed in both the 
crystal structures and through mass spectroscopy [42,44].  This phosphorylation 
event maintains the Pto activation loop in a conformation needed for interaction.  
The authors also show that AvrPto is capable of inhibiting Pto kinase function but 
that this function is not critical for the hypersensitive response [44].  They reason this 
inhibition of activity could be the virulence mechanism for AvrPto; thus, it may 
universally down-regulate kinase function through a common mechanism and 
achieve overall increased virulence.  Subsequently, it was shown that AvrPto and 
AvrPtoB can interact with other PRR kinase domains including FLS2 (AvrPto and 
AvrPtoB), EFR (AvrPto), BAK1 (AvrPto and AvrPtoB), and CERK1 (AvrPtoB) [46-
49]. The kinase domains of these PRRs also display a degree of sequence similarity 
and putative structural similarity (data not shown) illustrating a close relationship and 
possibly a global fold represented by the decoy Pto.  The various PRRs and 
receptor-like kinases found in plant immune signaling allow for selectivity of the 
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TTSS effectors on their host virulence targets while maintaining the eventual capture 
by Pto [50,51]. 
 
WXXXE families of TTSS effectors: Diverse Function for a Common Motif? 
 Small molecular weight GTPase proteins are common targets of TTSS 
effectors due to their integral roles in host signal transduction pathways, membrane 
trafficking, cytoskeletal dynamics, nuclear import, and other physiological processes 
[52].  GTPase proteins act as molecular switches existing in two confirmations, off 
(GDP bound) and on (GTP bound).  The conversion between these states is 
controlled by GTPase activating proteins (GAPs) (turns off) and guanine nucleotide 
exchange factors (GEFs) (turns on).  Over the past fifteen years a family of TTSS 
effectors has risen to the forefront of GTPase biology, providing insight into effector 
mimicry and target specificity. 
 The progenitor of this family is the Salmonella typhimurium TTSS effector 
SopE, which displayed GEF activity in the presence of the Rho-family GTPase 
Cdc42 [53].  SopE is a small protein with six α-helices arranged in two, V-shaped, 
helical bundles (Figure 1.4A) [54].  SopE is critical for virulence and invasion of the 
pathogen, which is dependent on the activity on Cdc42 [53].  However, SopE did not 
structurally resemble any known eukaryotic RhoGEFs (Figure 1.4A) [54].  When 
bound to Cdc42 the vast majority of SopE remains unchanged, but a small “catalytic 
loop” inserts in the switch 1 region of Cdc42 allowing for large rotations of the side 
chains present in this region and displacement of the guanine base (Figure 1.4A, 
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active site loop shown in red).  Switch 2 of Cdc42 moves closer toward the “catalytic 
loop” of SopE allowing for greater stability of the exchange reaction [54].   
More recently, a seemingly independent family of TTSS effector proteins from 
several species of mammalian pathogens (Salmonella, enteropathogenic and 
enterohemorrhagic E. coli, and Shigella) was identified as possessing Rho-family 
GTPase signaling capabilities [55].  This family was defined by an internal WXXXE 
motif [55].  This motif is required for proper function as missense mutations result in 
a loss of function for the effectors, but structurally conserved mutations allow for 
conservation of activity (W to Y and E to D) [55-57].  Initially, this family was believed 
to be molecular mimics of Rho-GTPase activity [55]. However, later studies revealed 
the structure of one of the family members, SifA, was solved and shown to posses a 
domain with a homologous fold to SopE, a known GEF [58].  Further research and 
structural determination has shown that other effectors in the WXXXE family also 
adopt the SopE fold and function as RhoGEFs (Figure 1.4A) [59,60].  While SopE 
lacks this WXXXE motif, it does possess a YXXXT motif with relative spatial 
conservation making it an intriguing possibility for either a degenerate motif or 
additional expansion of the signature of this motif (Figure 1.4A). 
WXXXE effectors utilize their GEF activity to subvert actin dynamics and gain 
entry into the host cell.  Injection of one of these members Map from EHEC/EPEC E. 
coli induces filopodia formation under the invading pathogen [61].  SifA is involved in 
proliferation and maintenance of the Salmonella-containing vacuole [62].  
Additionally, EspT from Citrobacter rodentium activates the immune response 
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through Rac1 to evoke a fever and eliminate other competing bacteria and allow for 
easier invasion of the host [57]. 
Analysis of the WXXXE family of proteins in comparison to eukaryotic 
RhoGEFs has also provided insight into defining specificity and selectivity for 
RhoGEFs among the TTSS effectors [59].  Specificity patches are defined in the β2-
β3 hairpin of the Rho-family GTPases and the α4/α6 helices of the WXXXE effectors 
[59].  Swapping of these regions allows for interchange of the individual specificity of 
each effector for each GTPase (Figure 1.4B) [59]. 
Hyun Ham et al. investigated the AvrE family of TTSS effectors from P. 
syringae for their relationship to the WXXXE effectors [63].  They found that each 
member of the AvrE family of effectors possesses at least one WXXXE motif, and 
that most posses two [63].  When missense mutations were made for both the 
tryptophan (W) and the glutamate (E), they saw a loss of function for the double 
mutant and motif deletion mutant, but not for either of the single mutants. This result 
differs from the findings analyzing several of the mammalian WXXXE TTSS effectors 
[55-57,63]. 
Noting this discrepancy, we compared the relative spacing of the WXXXE 
motif and looked for a “catalytic loop” and specificity patches within AvrE.  We were 
unable to find either using clustal X to align the sequences, the method used by 
Huang et al. 2009, or by manual analysis.  We then attempted to find structural 
homology by defining loose borders around the WXXXE motifs approximately 
correlating to the size (200aa) of the known WXXXE effectors (SopE, SopE2, BopE, 
Map, IpgB1, IpgB2, EspM1, EspM2, EspM3, EspT, SifA, SifB CopE).  We analyzed 
 16 
these sequences using HHpred and found that instead of showing structural 
homology toward the WXXXE family of RhoGEFs, AvrE shows homology to β-
propeller containing proteins and that the WXXXE motif aligns to a small helix in this 
domain.  While a single mutation likely would have no effect, a double mutation or 
deletion of this region could cause local instability resulting in disorganization of the 
propeller.  This finding does not negate the hypothesis that AvrE participates in G-
protein mediated signaling; in fact β-propeller proteins often serve as molecular 
scaffolds participating in G-protein signaling [64,65].  Additionally, the WXXXE motif 
is not a functional motif, but a structural motif forming a molecular clasp for the hinge 
between one to the helical bundles in the WXXXE family members [59].  This could 
be an example of a structural mechanism/motif that is more common than we had 
previously believed and should not be used as the exclusive definition of TTSS 
RhoGEFs. 
 
ADP-ribosylating Proteins: A Different Folds With a Common Function 
ADP-ribosylating toxins can be divided into 4 classes due to shared domain 
organization, mutual targets, and structural variance (Figure 1.5) [66].  While class 
members share structural features and modalities, sequence similarity can be low 
and restricted to motifs implicated in catalytic activity [1]. Eukaryotic ribosylating 
proteins also share structural identity with their prokaryotic counterparts.  The 
catalytic domain of poly(ADP-ribosyl) polymerase family shows homology to the 
catalytic domain of Diphtheria toxin and this homology is extended to the TTSS 
effector AvrRpm1 that will be discussed in detail in Chapter 2 [67].  Additionally, the 
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ecto-enzyme ART.2 shares structural homology with VIP2 from Bacillus cereus [68].  
All ADP-ribosyl transferases are denoted by a conserved core of 5 β-strands 
arranged as two abutting β-sheets [68]. The DT family introduces an additional β-
strand, an α-helix and a conserved H-Y-E catalytic triad whereas the VIP2 family 
introduces a seventh β-strand and an R-S-E catalytic triad [66,68]. 
ADP-ribosyl transferases are capable of catalyzing the removal of the 
nicotinamide moiety from NAD and facilitating the addition of the ADP-ribose moiety 
onto target substrates including H2O, antibiotics, RNA, DNA, and proteins [1,68,69].  
This reaction is known as ribosylation. Ribosylation effects protein function and can 
be promiscuous in nature, as in Pseudomonas aeruginosa Exotoxin S, or quite 
specific like Corynebacterium diphtheriae DT for the singular target elongation factor 
2 (eEF2) [68].  DT activity on eEF2 causes cessation of protein function whereas 
ADP-ribosylation of adenylate cyclase leads to constitutive activation [69].  
Ribosylation is targeted toward specific amino acid residues when proteins are the 
targets: R,C,N,E, and the histidine analog dipthamide [68,70].  Ribosylation is also 
reversible by a class of enzymes known as ADP-ribosyl glycohydrolases [69,71].  
ADP-ribosyl transferases are found in two varieties; those capable of catalyzing the 
addition of one ADP-ribose moiety (mono-ADPRTs, MARTS) or those capable of 
catalyzing the addition of multiple ADP-ribose moieties (poly-ADPRTs, PARTs, 
PARPs) [1,68-70].  ADP-ribosyl transferases are localized to many cellular regions: 
cell membrane, nucleus, secretory pathways, and cytoplasm [69].  ADP-ribosyl 
transferases are associated with diverse regulatory domains, DT must be cleaved 
and have its disulfide bond reduced before it is an active protein [72].  PARP-1 has a 
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DNA binding domain and an auto-modification domain and is not a competent 
enzyme until it is bound to DNA and has undergone auto-ribosylation [69].   
The ADP-ribosylation event has previously been implicated in plant immune 
responses.  When looking at the expression profiles elicited by avr-R gene 
interactions, genes encoding proteins responsible for the removal of ADP-ribose as 
well as the degradation of free ADP-ribose were up-regulated [73].  HopF1 (formerly 
AvrPphF) was crystallized and shown to have homology to ADP-ribosylating toxins 
but functional assays were indeterminate [74].  However, a homolog HopF2 has 
recently been shown to ribosylate Map Kinase Kinase 5 (MKK5) in the host to 
interfere with MTI initiated signaling events [75].  Additionally the TTSS effector 
HopU1 is able to ribosylate the RNA binding protein GRP7 in order to suppress MTI 
[76].  Again, we find that structural biology analyses give us insight into the 
molecular mechanisms by which TTSS effectors act on host targets. 
 
The dynamic interaction between the R proteins RPM1 and RPS2, their 
guardee RIN4, and the TTSS effector proteins AvrRpm1 
One main focus of the research presented in this dissertation is on the TTSS 
effector protein AvrRpm1.  AvrRpm1 was originally isolated from Pseudomonas 
syringae pv. maculicola [5,77]. Upon entering the host cell, AvrRpm1 is localized to 
the plasma membrane via myristoylation of the second (glycine) residue at its N-
terminus [6].  Transgenic over expression of AvrRpm1 allows for the TTSS deficient 
strain Pto DC3000hrcC to grow to increased levels on susceptible plants and 
suppresses callose deposition, implying that AvrRpm1 is capable of suppressing 
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MTI [78].  AvrRpm1 inhibits basal defense responses, such as callose deposition 
and early transcriptional activation of defense related genes GST6 and PR1 [79].  
Once localized, AvrRpm1 both associates with RIN4, as determined by co-
immunoprecipitation, and leads to its phosphorylation [80].  Phosphorylation of RIN4 
at T166 leads to the activation of RPM1 and further downstream defense responses 
that trigger the hypersensitive response and lead to partial suppression of 
PtoDC3000 (avrRpm1) growth [81].  In a disease susceptible plant (rpm1), AvrRpm1 
can contribute to the overall virulence of the pathogen [5]. AvrRpm1 can still 
contribute to virulence in the absence of RIN4, indicating that RIN4 is not the only 
virulence target in the host [82].  Further, when RPM1, is absent, conditionally over-
expressed AvrRpm1 elicits weak ETI by ‘off target’ RPS2 activation [83]. RPS2 is an 
R protein that monitors the cysteine protease cleavage activity of the TTSS effector 
AvrRpt2 on RIN4 [84].  The fact that cross-talk exists between two ETI pathways 
(RPM1 and RPS2) provides an intriguing framework for analysis into the nature of 
how Arabidopsis thaliana immune signaling complexes are structured; how R 
proteins relay signals they receive from their prospective guardees; how many 
guardees a single R protein is capable of monitoring; and how effectors like 
AvrRpm1 functionally subvert one ETI mechanism to be ensnared by another.  
These questions will be addressed in the second chapter of this dissertation.  
Development of a “medium-high-throughput” proteomics pipeline leads to 
structural determination of HopBA1 
The second main topic of the research presented here is the structural analysis 
of the novel TTSS effector HopBA1, which was identified through coupling high-
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throughput screens for effector identification to a simplified structural genomics 
project akin to SGCs [25,85,86].  TTSS effectors show low sequence identity with 
proteins of known function, making functional predictions difficult.  In order to 
identity the functions of P. syringae effector proteins, we applied structural 
characterization techniques to the TTSS effectors identified by sequencing 
initiatives with the goal that it would facilitate characterization of effector folds and 
identification of putative active site residues.  Beyond homology modeling we also 
tried to purify and crystallize some of these effectors, an effort that led to the 
solution of the crystallographic structure of HopBA1 (Chapter 3). 
 When we started this project, there were over 191 Pseudomonas syringae 
effectors to choose from representing ~50 families [25].  The first criterion for 
narrowing the list was to identify the effectors that had established biological 
significance.  This list included effectors that were of interest to us: HopAF1, a 
predicted deamidase; HopAM1 and HopBA1, effectors capable of eliciting HR on 
some but not all Arabidopsis thaliana accessions and thus defining new R proteins; 
and HopC1, HopH1 and HopAP1, three effectors with predicted homology to 
botulinum toxin. 
The second, independent criterion was to identify effectors that are part of 
different families but share a common domain.  These shared domains are proposed 
to arise through a process called “terminal reassortment” that allows for rapid 
evolution [87].  Two examples of this are the effector pairs HopD1 and HopAO1; and 
HopK1 and AvrRps4, each of which has a shared N-terminal domain and a divergent 
C-terminal domain.  Both pairs of effectors vary significantly in size from one 
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another: HopD1 is 710aa while HopAO1 is 468aa, and HopK1 is 338aa, while 
AvrRps4 is 221aa.  Further, it is known that the C-terminal domain of HopAO1 
functions as a tyrosine phosphatase and the C-terminal domain of AvrRps4 
functions in the virulence activity [26]. Such conclusions cannot be made about the 
function of HopD1 and HopK1 because little in known about them.   
The third, independent criterion was to analyze the sequences of the 
remaining families of effectors for secondary structure, predicted homology, 
predicted crystallization probability and the presence of orthologs in other TTSS 
using phytopathogens. Based on these analyses, each remaining family was 
classified using a priority scoring matrix. Constructs were generated for nine 
additional novel TTSS effector families identified through high-throughput structural 
initiatives [25].  We anticipated that structural characterization of these nine families 
will allow us to classify shared domains between two separate families, identify 
structural motifs common to Pseudomonas syringae effectors, possibly identify novel 
folds for known enzymatic functions as was the case for the Salmonella E3 ligase 
SspH2 [88], and allow us to compare how proteins from different organisms evolved 
to form the same functional domain from entirely different sets of amino acids.   
Using these criteria, we generated constructs for 20 families of effectors from 
Pseudomonas syringae and have performed preliminary analyses looking for 
regions of predicted disorder, regions of similarity among the effectors, and 
orthologous effectors in other pathogens with TTSS.  These effector families are at 
various stages of incorporation in the proteomics pipeline, and will not be discussed 
further here. They provide a rich resource for future projects. The most significant 
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outcome of this “medium-high throughput” proteomics pipeline was that we 
determined the crystal structure of the novel TTSS effector HopBA1 [25], which will 
be discussed in greater detail in Chapter 3. 
 
 
Summary 
Together, the studies described in this dissertation merge genome 
sequencing information with structural information gained from the study of TTSS 
effector proteins. This approach has yielded novel insights including structural 
homology between the TTSS effector AvrRpm1 and the poly(ADP-ribosyl) 
polymerase catalytic domain (Chapter 2), as well as the novel HopBA1 structure and 
its possible relationship to HopB1 and HopAC1 and the EreA-like/ ChaN protein 
superfamily (Chapter 3).  These relationships have enabled us to identify residues in 
each TTSS effector critical for perception by the host and have provided us with a 
platform for identification of target interfaces as well as future functional analysis. 
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Figure 1.1. The complex 
host-pathogen interactions 
involved in plant immune 
response. (A)	   When P. 
syringae first comes in 
contact with a host it is 
perceived by host PRRs 
such as FLS2. These PRRs 
recognize MAMPs such as 
the flagellar tail, and in 
specific the conserved 
peptide flg22.  This initiates 
MTI responses inside the 
host such as callose 
deposition and transcription 
of early defense response 
genes like PR1. (B) In the 
next stage of infection P. 
syringae undergoes a 
transcriptional and 
translational switch where it 
stops making some PAMPs 
like the flagellar tail and 
begins transcription of the 
hrp/hrc controlled genes 
which are responsible for 
maintence and assembly of 
the TTSS and associated 
effector proteins. (C)	   In the 
final stage of infection, the 
TTSS effectors are injected 
into the host and begin to 
manipulate host targets thus 
blocking MTI and leading to 
an increase in pathogen 
growth on susceptible hosts 
(left side).  These same 
beneficial manipulations can 
betray the pathogen on 
resistant hosts (right side) 
that have evolved R proteins 
to monitor changes of the 
target proteins (guardees) 
and initiate a subsequent 
defenses including but not 
limited to HR.	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Figure 1.2 The first interaction surface of  AvrPto with Pto, AvrPtoB with Pto, and 
AvrPtoB and BAK1 shows conserved features.  TTSS effectors AvrPto and AvrPtoB 
(blue) and their shared target Pto as well as the independent AvrPtoB target BAK1 
(orange).  Residues have been highlighted that form the conserved hydrophobic 
hydrogen bonds between the effectors (green) and the carbonyl of the glycine in the P+1 
loop of the targets (red).  Additionally residues implicated in functionality of the effectors 
(purple) and the targets (yellow) have been shown as side chains.	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Figure 1.3. Interaction surfaces vary both in location and in number when 
comparing the three TTSS effector: target interactions; AvrPto with Pto, AvrPtoB 
with Pto and AvrPtoB with BAK1.  TTSS effectors AvrPto, AvrPtoB121-205 and 
AvrPtoB250-359 are shown (blue tubes).  Interaction surfaces on Pto and BAK1 are 
highlighted; conserved surface 1 (P+1 loop) shown in red, and divergent surfaces 2 
(magenta) and 3 (light pink).	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Figure 1.4.  Structural conservation exists among SopE and the WXXXE family of 
TTSS effectors with target specificity for RhoGTPases arising on the α4/α6 helical 
interface. (A) Structural representations of SopE (1gzs) and Map (3gcg) with the YXXXT 
motif and the WXXXE motif shown in orange and the catalytic loop shown in red. (B) The 
α4/α6 interface is shown with residues implicated in selectivity for target RhoGTPases 
highlighted in magenta.	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Figure 1.5. Ribosylating toxins show varying degrees of structural similarity and have 
evolved different structural elements for a conserved function.  Structural representations of 
Cholera toxin (1XTC), Diphtheria toxin (1TOX), VIP2 (1QS1) and C3bot (1G24).  Structural 
elements that function in a conserved manner are colored the same with positioning and 
orientation of NAD depending on the blue, orange, green, and light blue structural elements, and 
catalysis dependent on the red.  The table contains information on the class of toxin and their 
target.  Each class has a representative structure depicted above. 	  
CHAPTER TWO 
AvrRpm1 missense mutations weakly activate RPS2-mediated immune 
response in Arabidopsis thaliana 
Introduction 
 This chapter was submitted to PLoS One on 5/15/2012. We completed all 
reviewer recommended revisions, resubmitted on 6/19/2012 and the manuscript was 
accepted on 7/9/2012.  An additional figure showing the purification of AvrRpm1 and 
analysis of the resulting protein has been included for this dissertation.  I completed 
all experiments in this chapter with the exception of the western blot analysis shown 
in Figures 2.7 and 2.8.  Brenda R.S. Temple provided guidance for the creation of 
the homology model and identification of ADP-ribosyl transferase motifs in AvrRpm1 
shown in Figure 2.1. 
 Pseudomonas syringae is a Gram-negative phytopathogen that utilizes 
various biochemical means, including analogous enzymatic activity or molecular 
mimicry of host proteins, to block or bypass the plant immune system. To achieve 
this, each P. syringae strain injects a suite of effector proteins into host cells using a 
type III secretion system. The type III secretion system is shared by many Gram-
negative pathogens of plants and animals that use effector proteins to subvert host 
cell physiology and bypass defenses [9,20,89]. Plants have evolved an elaborate 
intracellular detection system to recognize effectors that attempt to block or dampen 
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MAMP-triggered immunity (MTI), and reinitiate the blocked immune response [29]. 
Several well-studied nucleotide binding leucine-rich repeat (NB-LRR)-dependent 
responses to effectors are mediated by indirect recognition of effector action on a 
host target, as described by the Guard Hypothesis [27,29]. In this model effector 
targets function as a molecular lure or ‘guardee’, and a specific NB-LRR protein 
functions as a ‘guard’ [80,84,90,91]. Upon biochemical manipulation of the guardee 
by an effector protein, the NB-LRR protein is activated [27,29,92], leading to a 
successful immune response. In the absence of the corresponding NB-LRR, 
manipulation of the guardee can contribute to the virulence activity of the effector 
[29,80].  
 This work focuses on the characterization of Pseudomonas syringae type III 
effector protein AvrRpm1. AvrRpm1 function requires consensus fatty acid acylation 
sites including the myristoylation site of Gly2, likely followed by a subsequent 
palmitoylation site at Cys3 [6]. Once localized at the plasma membrane, AvrRpm1 
associates with RIN4, and, by an unknown mechanism, triggers its phosphorylation 
[80]. RIN4 phosphorylation is presumed to activate RPM1, and consequent 
downstream disease resistance responses. This model has been experimentally 
validated for a second, sequence diverse type III effector, AvrB, which targets the 
same RIN4 sub-domain targeted by AvrRpm1 to activate RPM1 [81]. In the absence 
of RPM1, AvrRpm1 [5] and AvrB [93] can contribute to overall pathogen virulence. 
Moreover, in the absence of both RPM1 and RIN4, AvrRpm1 still contributes to 
virulence [82], strongly suggesting that additional targets for AvrRpm1 exist in 
Arabidopsis. Targeting of RIN4 by two additional P. syringae effectors, AvrRpt2 [94-
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96] and HopF2 [91] suggest that RIN4 is a point of convergence in the arms race 
between pathogen effectors and critical host defense machinery [97]. 
 As type III effectors are the main contributors to the overall virulence of a 
phytopathogen, their myriad biochemical functions in the host cell have only recently 
started to be dissected; these include E3 protein ligase, phosphothreonine lyase, 
and ADP-ribosyl transferase activities [45,75,76,98]. Determination of molecular 
functions for type III effectors is complicated by their relatively low conservation at 
the primary amino acid sequence level to proteins of known biochemical function, 
suggesting convergent evolution onto structures that modulate eukaryotic signaling 
pathways [55,99]. Therefore, we used tertiary structure prediction in order to gain 
insight into AvrRpm1 function. We found that AvrRpm1 can assume the fold from the 
catalytic domain of poly(ADP-ribosyl)polymerase-1 (PARP-1).  
 
PARPs belong to a large family of proteins that contain additional domains beyond 
the canonical catalytic domain [100]. PARPs undergo self-modification by addition of 
ADP-ribose moiety(s) from NAD or function analogously on other targets. The 
addition of poly(ADP-ribose) (PAR) is reversible by poly(ADP-
ribose)glycohydrolases (PARGs) [101]. Poly(ADP-ribose) (PAR) can be toxic, often 
leading to inflammation, ischemia, and eventually cell death in mammalian systems 
[102]. Nudix O-acetyl-ADP-ribose hydrolases are responsible for the breakdown of 
free PAR within the cell [103]. The Arabidopsis genome encodes both PARGs and 
Nudix hydrolases, and both have been implicated in immune responses [73,104]. 
More generally, ADP-ribosylation of target proteins by toxins and type III effectors 
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results in the manipulation of host signaling and defense machinery in both plant and 
animals, as evidenced by the structurally related proteins Diphtheria toxin from 
Corynebacterium diphtheriae, ExoS from Pseudomonas aeruginosa, and HopF2 
from P. syringae, and the structurally unrelated HopU1 [1,75,105-107].  
 We demonstrate that the AvrRpm1 family of type III effectors shares the 
PARP catalytic fold, including key catalytic and structural components of PARP such 
as the catalytic triad H862-Y907-E998, which typically facilitates the ribosylation 
reaction. We use mutagenesis and functional tests to demonstrate that the 
conserved putative catalytic residues are required for AvrRpm1 to either elicit an 
RPM1-dependent immune response or contribute to virulence on a susceptible host. 
Furthermore, and quite intriguingly, we show that putative catalytically inactive 
AvrRpm1 inhibits the growth of P. syringae pathovar (pv.) maculicola on disease 
susceptible plants. This growth inhibition is dependent on activation of the NB-LRR 
protein RPS2. These findings support previous work suggesting that over-expressed 
AvrRpm1 has an ‘off target’ ability to trigger an RPS2-mediated defense response, 
and that RIN4 is not the only target for AvrRpm1 [82,108,109]. 
 Despite our inability to demonstrate enzymatic activity, due to inherent 
instability of purified AvrRpm1, our results collectively support the hypothesis that 
AvrRpm1 is a PARP-type ADP-ribosylating protein. Our data provide a starting point 
for identification of its substrate and for the definition of how that substrate 
contributes to RIN4 phosphorylation and inhibition of host defense. Our results also 
highlight the need for further understanding of the complex relationship between 
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RPM1, RPS2, RIN4 and RIN-like proteins that may also be functionally relevant in 
this system. 
 
Materials and Methods 
Creation of the Homology Models. The models were generated by querying the 
BioInfoBank Institute’s metaserver where we initially were able to detect homology 
with the catalytic domain of PARP-1. We compared sequence alignments generated 
with ClustalX, using the programs InSIGHTII, Accelrys Software Inc., and 
MODELLER [110-113]. We used PDB IDs: IUK0, IGS0, 1A26, and 3GJW as 
templates to generate a structural map for which we could align the AvrRpm1 
sequences. The model for the Psm allele was then evaluated for fitness using the 
Verify 3D application in InSIGHTII. 
 
Generation of AvrRpm1 mutants and P. syringae strains. Missense mutations for 
AvrRpm1 were generated by gene splicing [114]. The external PCR primers are 
Gateway™ compatible so that a common entry vector product could be used for the 
generation of multiple destination vectors. Pto DC3000, Psm CR299 carried the 
engineered missense mutations in trans on the pDLTrp plasmid, a Gateway™ 
compatible derivative of the pBBR1MCS vector [115] that uses a constitutively active 
tryptophan promoter. Missense alleles of AvrRpm1 were expressed in Pto DC3000 
as fusions to Δ79avrRpt2 as previously described [116]. An avirulent P. fluroescens 
(Pf0) strain that has been engineered to carry a stable integration of the hrp/hrc 
cluster as previously described [108] was transformed with different combinations of 
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the plasmids pVSP61 carrying avrRpt2 [93,117] or the pDLTrp plasmid mentioned 
above carrying either wild type avrRpm1 or the missense mutations.  
 
Electrolyte leakage and bacterial growth assay conditions. Electrolyte leakage 
assay has been described [84], modified to include 4 leaf discs in 6 mL of water. 
Bacterial growth in leaves was measured by inoculating 106cfu/mL into the leaves of 
4-5 week old plants. Leaf discs were extracted and ground in 10mM MgCl2 and 
serially diluted to measure bacterial numbers on the day of infiltration as well as 3 
dpi. ANOVA and a Tukey’s post-hoc analysis were performed on the 3pi data using 
the JMP ® Genomics software suite, SAS Institute Incorporated © 2012 to determine 
if there was a statistically significant difference among the growth levels of the 
various strains. Bacterial growth in seedlings was measured by dip inoculation as 
previously described [118]. Briefly, an inoculum of 105cfu/mL was made for Pto 
DC3000 carrying either an empty vector or avrRpm1 with missense mutations. 
Bacterial growth was measured on the day of inoculation as well as 3pi. 
Translocation assays were performed by inoculation of 4-5 week old plants with 5 x 
107 cfu/mL on one side of the leaf. Leafs were collected and photographed 20 hpi. 
 
Protein accumulation and immunoblot assay. For accumulation of proteins in 
plant tissue, leaf samples were ground in extraction buffer containing 20mM Tris pH 
8.0, 150mM NaCl,1% Triton X-100, 1mM EDTA pH 8.0, 0.1% SDS, 10 mM DTT 
Plant Protease Inhibitor Cocktail from Sigma-Aldrich. Ground tissue was centrifuged 
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for 20 minutes at 20,000 X g.  Supernatant was quantified by Bradford analysis, 
subjected to SDS-PAGE and immunoblot analysis. 
 
AvrRpm1 / AvrRpt2 RIN4 competition assay. Pfo strains described in the methods 
section for generation of AvrRpm1 mutants were infiltrated at 108 cfu/mL into 4-
week-old plants. Two leaves were collected for each time point and tissue was 
harvest as described above. Extracts were subjected to immunoblot analysis and 
probed with an α-RIN4 antibody generated from a highly specific and antigenic 
peptide of RIN4. 
 
Ribosylation Assay. Seedlings of either rpm1 or Dex::AvrRpm1-HA in rpm1 
genotypes were sparsely sown and grown on MS plates for 14 days [119]. The 
seedlings were then sprayed with a solution of 25mM dexamethasone (Sigma) and 
25nM biotinylated NAD (Trevigen). The protein was extracted using the protocol 
described in the protein accumulation and immunoblot assay methods. Duplicate 
preparations were made and one set was treated with phosphodiesterase type I 
(Sigma) in 110mM Tris pH 9.0, 110mM NaCl and 15mM MgCl2 [120]. The extracted 
protein was subjected to immunoblot analysis and probed using pre-conjugated α-
streptavidin (Thermo). For agrobacterium-mediated transient ribosylation assay we 
followed the protocol established in [81].  We then followed the protocol outlined 
above for labeling with biotinylated NAD and phosphodiesterase type I treatment. 
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Purification of AvrRpm1.  We generated ligation independent cloning constructs 
for full length AvrRpm1 as both 6X-His-TEV and GST-TEV fusion proteins and a Δ30 
AvrRpm1 (ΔTTSS) as a GST-TEV fusion protein for expression in E. coli BL21 (DE3) 
Rosetta ® cells.  An overnight culture of 50mL was grown with 50µL of 100mg/mL 
ampicillin and 17µL of 100mg/mL chloramphenicol.  One liter of Terrific Broth (TB) 
was inculated with 10mL of overnight culture and allowed to grown to and optical 
density of 0.6, λ=600nm.  The cultures were chilled in an ice water bath for 10 
minutes.  Induction of protein production was achieved with 100µL/L of 100mM IPTG 
followed by overnight incubation at 19°C.  Cell pellet was collected and lysed in 
20mM Tris, 200mM NaCl, 2mM DTT, and 5% glycerol using Avestin® Emulsiflex-C5.  
Cellular debris and insoluble material was centrifuged for 1 hour at 60,000 rpm in 
Beckman Culter® ultrafuge.  Soluble material was loaded onto a GST column in Tris 
pH 8.0, 200mM NaCl, 2mM DTT, and 5% glycerol and eluted in the same buffer with 
the addition of 40mM glutathione.  Protein was dialyzed in Tris pH 8.0, 200mM NaCl, 
2mM DTT, and 5% glycerol and TEV protease was added (at least 6 hours).  Salt 
concentration was titrated to 50mM and the protein was loaded onto a cation 
ammonia-group matrix (Q) column (high initial pH) for ion exchange 
chromatography.  Differential elution occurred upon the addition of a salt gradient 
over 20 column volumes with a buffer composition of Tris pH 8.0, 1M NaCl, 2mM 
DTT, and 5% glycerol.  The final eluted protein was concentrated using CetriPrep® 
concentrators (MW cutoff= 10kDa) and was brought to a final volume of 200µL at a 
concentration of 11mg/mL.  Ligation independent cloning constructs using 
pFASTBac™ t vectors were generated for both the Psm M6 and the Psp 2708 
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alleles of AvrRpm1 for use as a baculovirus expression system in Spodoptera 
frugiperda (Fall Armyworm) cells (Sf-9). Constructs for each allele included including 
the missense mutation G2A, double missense mutation G2A D185A, ΔTTSS and 
ΔTTSS D185A.  Upon successful cloning these constructs were used to transform 
DH10Bac™ cells and subjected to blue/white screening using disruption of the lacZα 
gene as incorporation of the pFastBac™ clone.  Bacmid purification products (high 
molecular weight DNA prep) was used to transfect SF-9 cells and generate primary 
virus.  Virus was collected and stored at °4C and cells were tested for relative 
expression of recombinant protein.  Constructs yielding highest levels of expression 
were used to generate secondary virus to be used to infect cell cultures for protein 
production.  1L cultures of SF-9 cells were grown to a final concentration of ~ 2 x 106 
and then inoculated with the secondary virus prep.  Cultures were allowed to grow 
for ~48 additional hours and then harvested immediately.  Protein purification from 
this point forward followed the protocol previously described for prokaryotic 
constructs. 
 
Native gel analysis of AvrRpm1.  Purified AvrRpm1 or RIN4 (see [121] for 
purification protocol) was diluted to a final concentration of 1mg/mL in Tris pH 8.0, 
200mM NaCl, 2mM DTT, and 5% glycerol. A total volume of 6µL was prepared for 
each sample (1µL of each protein alone, 1µL of each protein in combination, and 
then 1µL of RIN4 + increasing concentrations of RIN4.  A 12.5% native gel was run 
on the Amercham PhastGel system and stained with coomassie stain. 
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Circular dichroism (CD) of AvrRpm1 and RIN4. AvrRpm1 and RIN4 were purified 
as previously described except Phosphate buffer was substituted for Tris and NaF 
was substituted for NaCl to comply with accepted protocols for CD.  Molar elipticty 
(θ) measurements were collected from 185nm to 260nm for AvrRpm1 alone and 
AvrRpm1 in combination with RIN4.  
Results 
Identification of conserved structural homology and a putative PARP catalytic 
triad in AvrRpm1.  
We generated a computational homology model for AvrRpm1 to identify 
conserved structural domains shared with proteins of known function. After removing 
the first 30 residues, which are predicted to be disordered, we input the remaining 
AvrRpm1 amino acid sequence into the BioInfoBank Institute’s metaserver [122]. 
The highest-ranking outputs for predicted homologous folds from the aggregated 
databases were to various catalytic domains of poly(ADP-ribosyl)polymerase 
(PARP) [67,100]. PARP is a member of the larger family of Diphtheria toxin-like 
ADP-ribosyl transferases [1,66,70]. The catalytic domain of these proteins can be 
broken down into three regions (Figure 2.1A). The N-terminal region 1 is a span of 
primarily conserved residues highlighted by an aromatic residue (Figure 2.1A, 
denoted with φ) followed by the first catalytic triad member H63 (in AvrRpm1; all 
residues noted refer to the allele from Psm M6, GEN BANK ID AF359557.1 unless 
stated otherwise) and a glycine (G64). We also noted the presence of a conserved 
leucine (L62) preceding this region and a serine or threonine (T64) at its end in the 
majority of the PARP proteins. The centrally located region 2 is denoted by a pair of 
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tyrosine residues Y111 and Y122 separated by ten amino acids, where Y122 
corresponds to the second member of the catalytic triad. The C-terminal region 3 
contains the third catalytic triad residue, glutamate, or in the case of AvrRpm1 (Psm 
M6) aspartate (D185). Mutation of the glutamate residue to an aspartate did not 
abolish PARP-1 activity, but rather altered the in vitro kinetics [123]. The overall 
sequence identity between the catalytic domain of PARP-1 and AvrRpm1 is 
relatively low, however these regions and the relative spacing between them are 
conserved. 
 PARP-1 is a multi-domain protein [67], yet our homology model demonstrates 
that conservation with AvrRpm1 is limited to the catalytic domain. Hence, the model 
generated includes 70% of AvrRpm1, but only 16% of PARP-1. Our model begins at 
residue 49 of AvrRpm1 and extends until residue 203. The validity of our model was 
assessed using Verify3D, a program that compares the model generated and its 
own amino acid sequence [124]. The normalized average Verify3D score for the all 
residues in the model was 0.26, with a typical score around 1.0 for crystal structures 
and a typical score around 0.0 for incorrect folds.  On average, scores above 0.10 
reflect models with some structural validation.  While there are loop regions that 
could not be accurately modeled, it is important to note that the core fold is predicted 
to be conserved between the two proteins (Figure 2.1B). These loop regions and 
regions at the amino- and carboxy-terminus of the model represent local minima in 
Verify3D score while regions spanning the core fold represent local maxima in the 
Verify 3D score and for these reasons we are confident in our model build. Models 
were also generated for each of the remaining AvrRpm1 family members: from P. 
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syringae pvs. pisi race 6 (Ppi race 6), syringae B728a (Psy B728a), and 
phaseolicola 2708 (Psp 2708) (AJ251482.1, [125], AAY35802.1 [126], and Ps pv. 
phaseolicola 2708 (unpublished) respectively) using the same PARP-1 templates 
(PDB IDs: IUK0, IGS0, 1A26, 3GJW) [127-130]. The spacing identified using the 
original metaserver output for the P. syringae pv. maculicola AvrRpm1 allele, as well 
as an amino acid sequence alignment for the four additional AvrRpm1 alleles (Figure 
2.2), was used to create the remaining models (Figure 2.1C-E).  
 The Psm M6 and Ppi race 6 AvrRpm1 alleles share the highest identity, while 
the Psy B278a and Pph 2708 alleles are more divergent. Each AvrRpm1 family 
member, except that from Psy B728a, returned a structural match to either the 
PARP-1 catalytic domain (Ppi) or to PARP-12 and -15, smaller isoforms belonging to 
the PARP superfamily that contain only the catalytic domain (Pph 2708). We believe 
that the various programs aggregated in the metaserver were unable to identify a 
similar match for the syringae Psy B728a allele due to a seven-residue deletion that 
occurs between regions 2 and 3. This deletion alters the position of the third putative 
catalytic triad residue (Figures 2.1A and 2.2). 
 
Putative PARP catalytic triad residues are required for activation of RPM1 by 
AvrRpm1.  
Identification of a putative catalytic triad (H63-Y122-D185; Figure 1A) via 
homology modeling guided our introduction of missense mutations and subsequent 
functional tests following conjugation of mutant genes into Pto DC3000 (Methods). 
We assayed each of the three missense mutations (H63A, Y122A, D185A) for their 
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ability to elicit AvrRpm1-dependent activation of RPM1 as measured by cellular 
electrolyte leakage, a proxy for HR cell death (Figure 2.3A). We found that each of 
the missense mutations was compromised in their ability to trigger RPM1-mediated 
HR, comparable to a previously characterized loss of function, mislocalization 
mutant G2A [6]. We also assayed for the ability of the missense mutations to trigger 
RPM1-dependent growth restriction of Pto DC3000 in wild-type plants (Col-0) [131]. 
We found that Pto DC3000 carrying the missense mutations were, surprisingly, 
unable to grow (Figure 2.4). One interpretation of this result is that these missense 
alleles retain the ability to initiate RPM1-dependent growth restriction, but not HR. 
However, subsequent data presented below complicate this overly simple 
conclusion, and offer a clearer interpretation.  To ensure that the AvrRpm1 missense 
alleles were not merely compromised in their ability to traverse the type III secretion 
system, we cloned each loss of function mutant as a fusion protein to a truncated 
AvrRpt2 effector protein lacking the N-terminal 79 amino acids required for its own 
translocation [116]. These constructs were conjugated into Pto DC3000 and 
infiltrated into leaves of plants lacking RPM1, but expressing functional RPS2. These 
fusion effector proteins thus rely on the native type III secretion signals from 
AvrRpm1 for delivery into the host cell, but on the activity of Δ79AvrRpt2 to initiate 
RPS2-dependent HR. Each of the missense mutations was translocated via the type 
III secretion system (Figure 2.3B), an indication that the proteins are both expressed 
and stably accumulate to levels necessary for delivery into the host. 
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Putative PARP catalytic triad residues are required for the virulence function 
of AvrRpm1.  
Each AvrRpm1 missense mutation was tested for its virulence [5]. AvrRpm1 
missense mutations were expressed in P. syringae pv maculicola (Psm) strain M2 
CR299, which carries an insertion in avrRpm1 that disables this gene (CR299; [5]) 
(Figure 2.5A). Psm M2 CR299 carrying a wild type copy of avrRpm1 in trans grew at 
least ten-fold more than either Psm M2 CR299, or an isogenic strain that can deliver 
the mislocalized AvrRpm1 G2A missense mutant [6]. Each of the putative AvrRpm1 
catalytic triad missense mutations was also compromised for virulence mediated by 
AvrRpm1. In fact, the expression of these putative catalytic triad mutants inhibited 
the growth of Psm M2 CR299 to a higher extent with respect to CR299 or to CR299 
complemented with the localization AvrRpm1G2A mutant (Figure 2.5A). To determine 
if plasma membrane localization was required for this surprising phenotype, we 
tested the virulence activity of an AvrRpm1 double mutant in both the putative 
catalytic activity and localization/myristoylation (AvrRpm1G2A D185A). We found that 
this strain grew to levels equal to Psm M2 CR299 expressing the mislocalized 
missense mutation G2A (Figure 2.6). These data suggest that the missense 
mutations must be properly localized inside the host cell in order to inhibit the growth 
of Psm M2 CR299.  
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Missense mutations of AvrRpm1 proteins are perceived by the NB-LRR protein 
RPS2.  
Given the surprising result that Psm M2 CR299 strains expressing missense 
alleles in the putative catalytic triad of AvrRpm1 grew significantly less on 
susceptible rpm1 hosts than controls, we wanted to investigate the mechanism 
responsible for this effect. We generated two plausible hypotheses (1) AvrRpm1D185A 
binds its nominal target, or a new target, in an altered manner, causing sufficient 
target perturbation to activate an NB-LRR protein other than RPM1 to fire at low 
levels that are sufficient to limit pathogen growth; (2) AvrRpm1D185A is able to bind its 
nominal target, or a new target, in a manner that sequesters this target from other 
type III effector proteins delivered by Psm M2 CR299, preventing them from 
effectively contributing to that strain’s virulence. We assayed the ability of Psm M2 
CR299-derived strains carrying the AvrRpm1 missense alleles to grow on plants that 
are null for both the RPM1 and RPS2 NB-LRR disease resistance proteins (rpm1 
rps2), because RPS2 is an explicit candidate for weak recognition of AvrRpm1 [108]. 
In fact, Psm M2 CR299 expressing AvrRpm1D185A grew as well as the loss of 
function mislocalization allele, AvrRpm1G2A in leaves of rpm1 rps2. Thus, the ability 
of AvrRpm1D185A expression to inhibit the growth of Psm M2 CR299 is due to weak 
activation of RPS2 that is insufficient to trigger macroscopic HR (Figure 2.3A and 
2.5B). We observed the same growth patterns of Psm M2 CR299 expressing the 
AvrRpm1 missense alleles on susceptible rpm1 rps2 rin4 plants (Figure 2.5C). Each 
of the AvrRpm1 missense mutations used in this assay accumulated normally in P. 
syringae (Figure 2.5D) and, as noted above, was translocated (Figure 2.3B). 
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Together, these results demonstrate that the ability of the AvrRpm1D185A to restrict 
growth of an otherwise virulent pathogen is dependent on its myristoylation and 
localization at the plasma membrane, and its ‘off-target’ perception there by RPS2. 
 
Missense alleles of AvrRpm1 do not show increased interference with AvrRpt2 
cysteine protease activity on RIN4.  
The type III effector AvrRpt2 functions as a cysteine protease that directly 
interacts with RIN4, cleaving it at N- and C-terminal RCS (RIN4 cleavage sites) 
resulting in rapid degradation of the remaining RIN4 fragments [78,95,96]. One 
hypothesis to explain the results reported above is that AvrRpm1 prevents binding 
and cleavage of RIN4, or a RIN4-like substrate, by AvrRpt2. In this model, this 
blockade of the proposed substrate’s ability to interact appropriately with RPS2 
would lead to ectopic RPS2 activation in the same manner that RIN4 is genetically 
required to negatively regulate an otherwise lethal activation of RPS2 [82,84]. Thus, 
AvrRpm1 and its missense alleles were tested for their ability to directly inhibit the 
ability of AvrRpt2 to cleave RIN4. Each AvrRpm1 missense mutation was expressed 
in trans together with AvrRpt2 in Pseudomonas fluorescens, a non-pathogen 
engineered to carry a competent type III secretion apparatus [108]. The ability of 
AvrRpt2 to cleave RIN4 leading to the overall disappearance of RIN4 over time was 
assayed via western blot analysis using native RIN4 antisera (Figure 2.7). Neither 
wild type AvrRpm1 nor the missense alleles consistently inhibited the cleavage and 
clearance of RIN4 by AvrRpt2 by 6 hours post-infection (Figure 2.8), consistent with 
the lack of effect of RIN4 on the growth suppression phenotype displayed by the 
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AvrRpm1 missense alleles. However, we reproducibly detected attenuation of 
cleavage and clearance of RIN4 by AvrRpt2 in the presence of wild type AvrRpm1, 
mislocalized AvrRpm1G2A or the putative non-functional AvrRpm1D185A. The double 
mutant AvrRpm1G2A D185A reproducibly lacked this ability. We speculate that this 
attenuation is due to weak inhibitory activity of mislocalized, but functional, 
AvrRpm1G2A on RIN4 [6], and a similar inhibitory activity of properly localized, but 
non-functional, AvrRpm1D185A on RIN4. The lack of attenuation of RIN4 cleavage by 
AvrRpt2 observed for AvrRpm1G2A D185A can be explained by the combined loss of 
function of the two single mutants. In sum these data do not eliminate the possibility 
that the AvrRpm1 missense alleles exhibit their novel phenotype via binding to 
another RIN4-related target more tightly than does the wild type AvrRpm1, leading to 
a previously undefined activation of RPS2 and subsequent pathogen growth 
suppression.  
 
AvrRpm1 may function as a molecular mimic of ADP-ribosyl transferases.  
We have tried to ascertain whether AvrRpm1 functions as an ADP-ribosyl 
transferase using established assays [75]. However, we were unable to successfully 
purify AvrRpm1 to homogeneity as a soluble and folded protein (discussed below). 
We tested the ability of AvrRpm1 to catalyze a ribosyl-transferase reaction using 
biotinylated nicotinamide adenine dinucleotide (NAD) as a substrate in a 
dexamethasone inducible transgenic plant line expressing AvrRpm1, and found that 
there appears to be no alteration in ribosylation state due to the presence of 
AvrRpm1 (Figure 2.9). To confirm that we were indeed assaying for ribosylation we 
 45 
treated duplicate cellular extracts with phosphodiesterase, which cleaves the ester 
bond in the ADP-ribose moiety, freeing the biotin label (Figure 2.9A). This 
ribosylated band appears to be of the same molecular weight as the endogenously 
ribosylated protein identified by Wang et al. in April 2011 [132]. We also tested for 
direct activity on RIN4, as well as any alteration in ribosylation signatures between 
wild type AvrRpm1 and D185A using a transient expression system in N. 
benthamiana [81], but again observed only what appeared to be an endogenous 
ribosylation event (Figure 2.9C). In the absence of additional functional tests, it also 
remains plausible that AvrRpm1 functions as a molecular mimic of an ADP-ribosyl 
transferase, and blocks that enzyme’s function. 
 
Soluble, purified AvrRpm1 is highly susceptible to degradation and does not 
show signs of discrete regions of secondary structure.   
We generated several purification constructs for AvrRpm1 (see methods) and 
attempted to purify these proteins to homogeneity.  We found that while both the 6X-
His-AvrRpm1 (insoluble) and GST-AvrRpm1 (slightly soluble) showed varying 
degrees of poor solubility, a deletion construct of the first 30 amino acids (ΔTTSS) 
which are predicted to be disordered (data not shown) combined with a GST affinity 
tag, we recovered soluble protein (Figure 2.10A).  However this protein is highly 
susceptible to degradation throughout the various steps of purification despite the 
presence of protease inhibitors (Figure 2.10A).  Additionally when we tested for in 
vitro interactions with AvrRpm1 and RIN4 using native gel analysis we observed that 
AvrRpm1 was not able to diffuse into the native gel and instead remained in the 
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stacking gel (Figure 2.10B).  This led us to hypothesize that purified AvrRpm1 was 
unable to maintain its native confirmation.  To confirm this hypothesis we performed 
circular dichroism to determine if there are any discrete regions of secondary 
structure within AvrRpm1 and if this is altered in the presence of RIN4 (Figure 
2.10C).  We observed no signature of secondary structure from the molar ellipticity 
of AvrRpm1 (α- helix shows twin troughs at ~208nm and 222nm and β-strands has 
one trough at ~215nm) (Figure 2.10C).  There is a very slight potential shift toward a 
protein with β-strand confirmation, however this is believed to be due to the small 
structural contribution of RIN4 (Figure 2.10C).  Taken together these data confirm 
that purified AvrRpm1 does not maintain a folded confirmation and may require 
either a post-translational modification or a folding partner in the host for proper 
folding to occur.  In order to test this hypothesis we tried expressing both the Psm 
M6 and the Psp 2708 alleles of AvrRpm1 using a baculovirus expression system in 
Spodoptera frugiperda (Fall Armyworm) cells (Sf-9). Constructs for each allele 
included including the missense mutation G2A to prevent localization to the 
membrane; double missense mutation G2A D185A to purify a putatively inactive 
protein; ΔTTSS and ΔTTSS D185A to remove the predicted disordered regions. As 
with the prokaryotic expression systems we were unable to recover folded protein 
and these constructs proved to be soluble aggregates (data not shown). 
 
Discussion 
 We demonstrate that the type III effector protein AvrRpm1 displays a 
homologous fold to ADP-ribosyl transferases (Figure 2.1A and B). This homology 
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extends to residues (H63-Y122-D185) that are required for both AvrRpm1 virulence 
and recognition of AvrRpm1 by the NB-LRR protein RPM1 (Figure 2.3A). Mutation of 
the putative catalytic residue D185 results in a unique loss of virulence phenotype on 
susceptible plants; this phenotype is suppressed when this protein is mislocalized 
(Figures 2.5A and 2.6). This phenotype reflects the recognition of AvrRpm1D185A by 
the NB-LRR protein RPS2 (Figure 2.5B).  A summary of these findings can be found 
in Figure 2.11. Additionally, this phenotype is not altered by the absence of RIN4 
(Figure 2.5C) and the missense alleles do not contribute to an increase in 
interference with AvrRpt2 cleavage of RIN4 (Figure 2.8). 
The poly(ADP-ribosyl)ation reaction in mammalian systems is involved in 
stress signaling, chromatin modulation, transcriptional regulation, proteasome 
activation and cell death [102]. ADP-ribosylation is employed by microbes to 
manipulate eukaryotic host cell signaling machinery. Diphtheria toxin from 
Corynebacterium diphtheriae and ExoS from Pseudomonas aeruginosa are 
virulence effectors for pathogens of mammals that target elongation factor 2 (EF-2) 
and Ras GTPase, respectively [70]. 
 There is growing evidence that ADP-ribosylation plays a critical role in 
phytopathogenicity as well as in plant immune responses. While no biochemical 
function has been attributed to P. syringae AvrPphF/HopF1, this effector adopts a 
fold similar to members of the Diphtheria toxin family of ADP-ribosyl transferases. 
Missense mutation of the catalytic histidine and glutamate residues led to both loss 
of the ability to trigger efficient disease resistance on resistant bean cultivars, and a 
decrease in pathogen growth on susceptible bean cultivars [74], analogous to our 
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findings. Despite the inability to assign a biochemical function to HopF1, the 
homologous type III effector HopF2 has been shown to possess ADP-ribosylation 
activity on MAP kinase kinase 5, leading to inhibition of MTI [75]. Additionally 
HopU1, which is structurally similar the Cholera toxin family, is able to catalyze the 
addition of ADP-ribose onto the glycine rich RNA-binding protein GRP7, a 
component of plant innate immunity [76,106]. 
 Beyond direct targeting of ADP-ribosyl transferase toxins to host substrates, it 
appears that the host ADP-ribosyl transferase pathway itself is activated during 
immune response: genes encoding both PARG and Nudix hydrolases are up-
regulated in the presence of MAMPs, in particular the flagellar peptide-flg22 [73]. 
Given these host responses to MAMPs, it is plausible that non-functional ADP-
ribosyl transferase proteins could also interfere with wild type cellular outputs, as we 
postulate may occur for AvrRpm1. Hence, our results coincide with the increasing 
evidence that the ADP-ribosylation pathway plays a critical role in the interplay 
between phytopathogen and host.  
 AvrRpm1 appears to function as a molecular mimic of ADP-ribosyl 
transferases; whether it has enzymatic activity remains unknown. We could not 
determine a biochemical function for AvrRpm1, despite our demonstrated genetic 
requirement for intact residues analogous to those forming the PARP catalytic triad. 
We attempted to purify both wild type AvrRpm1 and AvrRpm1D185A, as well as the 
most divergent allele P. syringae pv. phaseolicola 2708 from various sources. In all 
cases, the homogenous protein we recovered did not maintain folded conformation. 
To side-step these challenges, we utilized transgenic plant lines conditionally 
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expressing AvrRpm1 and modified the ADP-ribosylation assays presented in Wang 
et al. [75] to define its biochemical function and potential substrate(s). However, we 
did not observe increased ADP-ribosylation compared to background levels (Figure 
2.9). Additionally the band that is ADP-ribosylated in this assay is approximately the 
same size as a band that was identified previously as an endogenously ADP-
ribosylated protein in Arabidopsis [132]. We cannot rule out that our current assays 
are below detection threshold for identification of AvrRpm1 ADP-ribosylation activity. 
Additionally, the transient nature of the reaction and its reversal by PARG may 
interfere with accurately capturing targets in a whole cell context. Further work will 
need to be done on isolation of AvrRpm1 and identification of target proteins so that 
direct biochemical analysis may be performed. 
 Chisholm et al. [94] proposed that AvrRpm1 evolved to block RIN4-mediated 
MAMP defenses, and that this led to the evolution of RPM1. In their model, AvrRpt2 
evolved to overcome AvrRpm1-dependent activation of RPM1, and RPS2 evolved to 
prohibit its function. Both RPM1 and RPS2 demonstrably monitor the integrity of 
RIN4 [80,82,84]. However, the work presented above, and previous findings show 
(1) that RIN4 is dispensable for AvrRpm1 and AvrRpt2 virulence function [82,109]; 
(2) that both RPM1 and RPS2 can be activated by over-expression of wild type 
AvrRpm1 [80,108]; and (3) that AvrRpm1 and AvrRpt2 are, to date, never found in 
the same strain [5,25,78,80,82,84,108]. 
Importantly, Kim et al. [108] demonstrated that over-expression of AvrRpm1 
can activate RPS2 in rpm1 plants; this activation was not directly attributed to an 
alteration in the phosphorylation state of RIN4. They hypothesized that what were 
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once believed to be phenotypic cytotoxic indicators of ‘effector virulence activities’ 
are actually the phenotypes of weak ETI [108]. Our work supports this finding, in that 
RPS2 is activated by the AvrRpm1D185A catalytic missense allele delivered at near 
wild type levels from P. syringae or P. flourescens.  
 This surprising result could be due to several factors. First, AvrRpm1 is likely 
to have multiple homologous targets within the host [82], as with AvrPto and 
AvrPphB targeting multiple receptor kinases and receptor-like kinases [49,133], or 
AvrRpm1 may target multiple unrelated proteins analogous to HopF2’s activity on 
both RIN4 and MEKK5[75,91]. Second, AvrRpm1D185A could either bind more tightly 
to, or be less able to release from, an RPS2-associated target protein than the wild 
type AvrRpm1. Our results reinforce the evidence that RIN4 is not the only AvrRpm1 
target in Arabidopsis [40,82], and re-focus attention onto the other ten members of 
the RIN4-like NOI-domain containing proteins in Arabidopsis [78,96]. RPS2 exists in 
a lipid raft with other components that contribute to immune signaling, potentially 
including RPM1 and the flagellin receptor FLS2, and can be cross linked to these 
components [134]. Thus, there exists the intriguing possibility that RPS2 can also 
monitor perturbation of alternative target(s). Experimental analysis of this idea is 
difficult, since rin4 mutation is lethal in the presence of RPS2 [84]. Immune signaling 
in Arabidopsis may thus function like “bells on a string”- when one part of the 
signaling complex gets perturbed the rest makes a sound with the amplitude and 
relative “pitch” modified by the composition of the signaling complex, even in the 
absence of what was previously believed to be the major component, as we 
observed for weak activation of RPS2 in the absence of RPM1.   
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Figure 2.1 (previous page). AvrRpm1 exhibits structural homology to the catalytic 
domain of Poly-ADP-ribosyl polymerase (PARP). (A) Sequence alignment of DT 
family ADP-ribosylating proteins [1] and the four AvrRpm1 family proteins illustrating key 
regions of conservation. Secondary structure for each region is shown above. Highly 
conserved residues are highlighted in blue. Red carets denote the catalytic triad of 
PARP. (B) Homology model of the AvrRpm1 reference allele (copper) from P. syringae 
pv. maculicola M6 (Psm M6) with the catalytic domain of Poly-ADP-ribosyl polymerase 1 
(PARP-1; PDB ID: 3GJW) (silver). The side chains for residues highlighted in (A) are 
denoted by dark blue (AvrRpm1) and light blue (PARP-1). Residues in the catalytic triad 
are labeled according to AvrRpm1. “N” and “C” represent the amino- and carboxy-
terminus of the protein respectively. Independent homology models for the remaining 
three AvrRpm1 family members from (B) P. syringae pvs. syringae B728a (Psy B728a), 
(C), pisi race 6 (Ppi race 6) (D), and phaseolicola 2708 (Psp 2708).	  
Figure 2.2. Alignment of AvrRpm1 alleles. Alignment of AvrRpm1 alleles generated 
with ClustalX. Conserved regions between PARP and AvrRpm1 are highlighted in light 
blue. 	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Figure 2.3. Missense mutants of AvrRpm1 do not elicit an RPM1-mediated 
hypersensitive response, but can be translocated. (A) Four week old Col-0 plants 
were hand inoculated with 5x107 cfu/mL Pto DC3000 carrying either an empty vector or 
avrRpm1 with missense mutations eliminating localization to the membrane (G2A) [6], to 
the putative catalytic triad (H63A, Y122A, and D185A) and a double mutant (G2A D185A) 
and assayed for the ability to promote electrolyte leakage via RPM1-mediated 
hypersensitive response (HR) (see Methods). Error bars represent 2x SEM. (B) Five 
week old rpm1 RPS2 plants were infiltrated with 5x107 cfu/mL Pto DC3000 carrying 
missense mutations of avrRpm1 cloned to produce fusion proteins with Δ79avrRpt2. The 
ability to elicit an RPS2-mediated hypersensitive response was assayed at 20 hours post 
inoculation (HPI). Leaf counts (HR positive / total inoculated) are displayed under 
representative leaves.	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Figure 2.4. Pto DC3000 expressing AvrRpm1 missense mutations cannot grow on 
wild type plants. Two week old Col-0 seedlings were dipped into an inoculum with 105 
cfu/mL Pto DC3000 carrying either an empty vector or avrRpm1 with missense mutations 
eliminating localization to the membrane (G2A) [6], or in putative catalytic triad (Y122A 
and D185A) and a double mutant (G2A D185A). Samples were assayed for bacterial 
growth on day 0 and day 3.  Error bars represent 2x SEM. 	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Figure 2.5. Putative catalytic triad 
residues are required for AvrRpm1 
virulence that is inhibited via weak 
activation of RPS2-mediated 
disease resistance. (A - C) Growth 
of Psm CR299, a derivative of Psm 
M2 that carries an insertion in 
avrRpm1 [5] was complemented in 
trans with plasmids expressing wild 
type AvrRpm1 and missense 
mutations as noted. Four week old 
rpm1 (A), rpm1 rps2 (B) or rpm1 rps2 
rin4 (C) plants were inoculated with 
106 cfu/mL and samples were 
collected on day 0 and day 3. Error 
bars represent 2x SEM. An analysis 
of variance (ANOVA) was performed 
among the day 3 samples followed 
by Tukey’s post-hoc analysis (α= 
0.05) with significance groups 
indicated by letters on the graph. (D) 
Immunoblot assay for accumulation 
of the wild type and mutant AvrRpm1 
proteins at 3 days post inoculation for 
strains used in (B) and (C).	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Figure 2.6. A mislocalized AvrRpm1 double mutant, G2A D185A does not limit 
virulence. Growth of Psm CR299 (carrying an insertion in avrRpm1) was complemented 
in trans with avrRpm1 and the indicated missense mutations. Leaves of 4-week-old rpm1 
plants were inoculated with 106 cfu/mL and samples were collected on day 0 and day 3. 
Error bars represent 2x SEM. An analysis of variance (ANOVA) was performed among 
the day 3 samples followed by Tukey’s post-hoc analysis (α= 0.05) with significance 
groups indicated by letters on the graph.	  
Figure 2.7. Generation of new antibody using RIN4 specific peptide. New antibody 
against RIN4 was generated against peptide from amino acids 57 to 69 
(PSSRTKPEQVDTV) based on high antigenicity and sequence uniqueness. Immunoblot 
analysis was performed on wild type (Col-0) and plants lacking RIN4 protein (rpm1 rps2 
rin4).	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Figure 2.8. AvrRpm1 mutants do not exhibit increased interference with AvrRpt2-
mediated cleavage of RIN4. Pfo expressing wild type AvrRpt2 and either wild type or 
AvrRpm1 missense mutations in trans was infiltrated into leaves of 4-week-old rpm1 rps2 
plants at 108 cfu/mL. Samples were collected over a time course (as indicated) and 
probed for the presence of RIN4 as an output of AvrRpt2 function. 
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Figure 2.9. AvrRpm1 does not preferentially ribosylate Arabidopsis proteins, or 
RIN4. (A) Two week old seedlings were sprayed with a solution of 25mM dexamethasone 
and 25nM biotinylated NAD. Seedlings were collected 12 hours later and a duplicate 
sample was treated with PDE type I to remove the ribosylation modification. Samples 
were then subjected to immunoblot analysis with α-streptavidin antibody. (B) Replicate 
samples as in (A) subjected to immunoblot analysis α-HA antibody for expression of 
AvrRpm1-HA. (C) N. benthamiana was left un-infiltrated or was infiltrated with A. 
tumefaciens carrying RIN4 and either estradiol inducible AvrRpm1-HA or AvrRpm1D185A-
HA. Upon induction of AvrRpm1 expression, leaves were also treated with biotinylated 
NAD and six hours later samples were collected and subjected to immunoblot analysis. 
Figure shows expected apparent molecular weight range for RIN4 (23kDa). (D) Replicate 
samples as in part (C) subjected to immunoblot analysis α-HA antibody for expression of 
AvrRpm1WT and AvrRpm1D185A and α-T7 antibody for expression of RIN4.	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Figure 2.10. Soluble, purified AvrRpm1 is highly susceptible to degradation and 
lacks defined secondary structure. (A) SDS-PAGE analysis of elution from GST 
column (left), source-Q ion exchange column (middle) and concentration of final 
purification product (right) showing degradation products of AvrRpm1 throughout the 
purification process.  (B) 12.5% Native gel of AvrRpm1 and RIN4 alone and in 
combination, with increasing concentrations of AvrRpm1. (C) CD spectra of AvrRpm1 
alone (blue) and in combination with RIN4 (red)	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Figure 2.11. AvrRpm1 lead to a loss of HR mediated by the resistance 
protein RPM1 while simultaneously triggering RPS2 mediated growth 
suppression.  Schematic summary of results.  Plasma membrane (grey), 
mutant AvrRpm1 (pink), RIN4 (green), RPM1 (blue), RPS2 (purple), immune 
response effects (red) 
CHAPTER THREE 
Structural and functional analysis of the type III effector HopBA1. 
Introduction 
The following chapter will be published in conjunction with work performed by 
Marc Nishimura on identification of targets of, and receptors for, HopBA1.  I will 
share co-first authorship.  I performed all experiments presented in this chapter 
except those seen in figures 3.8B-D and the esterase assay mentioned in the text 
(Marc Nishimura).  Crystallographic data collection and analysis were performed 
under the supervision of Mischa M. Machius.  Homologous fold determination and 
analysis were performed under the supervision of Brenda R.S. Temple. 
As mentioned in the introductory chapter, we established a “medium-high-
throughput” proteomics pipeline for the structural and functional characterization of 
TTSS effectors. This proteomics pipeline was re-prioritized as a direct effect of both 
sequencing initiatives and multi-ecotype phenotypic screens for effector recognition 
(using the HR as the output assay) carried out in the Dangl lab [25].  These efforts 
led to the identification of nine novel families of TTSS effectors, in particular HopBA1 
(Pseudomonas syringae pathovars aptata strain DSM 50252 and japonica strain 
M301072PT) [25] which was able to elicit the hypersensitive response on two (Ag-0 
and Ws-0) out of 96 tested inbred accessions of Arabidopsis thaliana (data to be 
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published).  The first step toward identifying a function for HopBA1 was sequence 
analysis and homology modeling to identify any shared folds with known proteins, as 
was done with AvrRpm1 (Chapter 2); however, this was unsuccessful. Instead, both 
X-ray crystallographic techniques as well classical genetic approaches were used to 
attempt to determine the molecular function of HopBA1 and its associated 
targets/receptors.  This chapter will discuss in detail the methodology and insight 
gained from our successful structural characterization of HopBA1. 
 
Methods and Results 
 
Expression and purification of recombinant HopBA1 
A glutathione-S-transferase (GST) affinity tag purification construct was 
generated for full length HopBA1 using ligation independent cloning [135].  
Expression was carried out in Novagen® Rosetta™ E. coli BL21(DE3) cells.  A 5mL 
overnight culture was used to inoculate 1L of Terrific broth (TB) with 1mL of 
100mg/mL ampicillin and 33mg/mL chloramphenicol.  Cells were grown at 37°C to 
an optical density of 0.5 at λ=600 (~3.5-4 hours), incubated in an ice-water bath for 
ten minutes and protein production was induced with 0.1mM IPTG.  Cells were 
returned to an incubator at 19°C to allow for overnight induction of protein.  
Purification was achieved with tandem GST affinity purification with an intervening 
tobacco etch virus (TEV) cleavage step coupled with size exclusion 
chromatography.  Initial buffer composition included 20mM Tris pH 7.5, 150mM 
NaCl, 2mM DTT, and 5% glycerol in the affinity column steps, TEV cleavage, and 
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the size exclusion chromatography step.  Addition of 40mM glutathione was used to 
elute the bound portion from the column during the first round of affinity purification.  
Bound material from subsequent rounds of affinity purification was discarded, as 
they were either uncleaved protein or GST affinity tag.  During size exclusion 
chromatography, we found that purified HopBA1 elutes as a monomer (~25 kDa) 
whereas remaining GST forms obligate dimers (~52 kDa).  HopBA1 was 
concentrated to 13mg/mL correlating to 430µM. 
 
Crystallization of HopBA1 
Crystallography trials for purified HopBA1 were initially prepared using 
hanging drop vapor diffusion methods in 4 different commercially available crystal 
screens [136].  These screens varied salts, salt concentrations, precipitants, and pH 
ranges under three different ratios of protein to mother liquor in the drops (1:1, 2:1, 
and 1:2 protein: mother liquor).  From this initial screen, 20 conditions yielded 
crystals. The largest crystals (70µm in length grown in 0.5M LiSO4, 0.1M HEPES pH 
7.5, 25% v/v PEG 600, and 5% v/v glycerol; Figure 3.1A) were selected to collect a 
sample diffraction data set.  These crystals yielded diffraction to approximately 4Å at 
room temperature.  
 
Crystal optimization of HopBA1 
 In an effort to improve diffraction, these trial conditions were expanded across 
pH, precipitant, salt concentrations, and temperature.  Crystals that were 100µm in 
length and slightly less in width were grown in 6µL hanging vapor diffusion drops 
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with a protein: mother liquor ratio of 1:1.  Buffer conditions of 0.5M K2SO4, 0.1M 
HEPES pH 7.0, and 30% v/v PEG 400 (Figure 3.1B) or 0.5M Li2SO4, 0.1M Tris pH 7, 
and 30% v/v PEG 400 (Figure 3.1C). 
 
Collection of a native data set for HopBA1 
Native HopBA1 crystals showed a preliminary diffraction reaching 2.8Å over 
0.5º of rotation. These crystals were then sent to the SER-CAT beamline 22-ID at 
the Advanced Photon Source at Argonne National Labs. 
 
Optimization of HopBA1 seleno-methionine crystals, anomalous data 
collection and structure determination. 
All diffraction data generated must anticipate a means for overcoming the 
phase problem from which the absolute origin of the diffraction from the native data 
set cannot be determined.  This can be overcome by two methods: insertion of an 
anomalous signal in the crystal lattice or utilization of molecular replacement when 
solving the structure of the protein.  Since the structure of HopBA1 had not been 
solved previously we relied on an anomalous signal as the source of our phase 
determinant.  The GST-HopBA1 construct used previously was transformed into the 
methionine auxotroph E. coli BL21 834 (DE3) and grown in the presence of seleno-
methionine.  Seleno-methionine incorporation allowed us to collect anomalous data 
sets that were used for phasing and structure determination of HopBA1 [137]. 
HopBA1 has four internal methionines that were substituted with seleno-methionine 
to generate detectable anomalous signal.  We purified HopBA1 under the exact 
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conditions mentioned previously.  The initial buffer composition included 20mM Tris 
pH 7.5, 150mM NaCl, 2mM DTT, and 5% glycerol in the affinity column steps, TEV 
cleavage, and the size exclusion chromatography step.  Addition of 40mM 
glutathione was used to elute the bound portion from the column during the first 
round of affinity purification.  A final concentration of 11.9mg/mL was achieved.  We 
next set up hanging vapor diffusion drops over 0.5M K2SO4, 0.1M HEPES pH 7.0, 
and 30% v/v PEG 400.  We found that seleno-methionine substituted HopBA1 grew 
into much smaller crystals when compared to wild type HopBA1.  We again tried 
screening around different pH, precipitant, salt concentrations, and temperatures.  
Ultimately, we found that by simply lowering the overall protein concentration by 
10% to 10.7µg/mL we were able to grow crystals of approximately 120µm in size 
(Figure 3.1D).  Single-wavelength anomalous dispersion (SAD) data sets were 
collected from several crystals to completion at 3.3 Å on SER-CAT beamline 22-BM.  
These data along with the native diffraction data were used to solve the structure for 
HopBA1.  An initial complete model for HopBA1 was built using the SAD data set, 
COOT [138] and two slightly different initial model builds from PHASER [139,140] 
crystallographic software.  These models were manually combined in COOT and 
refined based on the experimental electron density using the REFMAC [141,142] 
application in the CCP4i [143] software package.  This process was repeated 
through several rounds of refinement until an acceptable model was generated for 
the SAD data set. This model was then used to solve the structure of native HopBA1 
utilizing molecular replacement. We completed the refinement for HopBA1.  
Refinement of the native data set utilized CCP4i’s REFMAC application as well as 
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Phenix [139].  The structure was modeled using data to 2.01 Å.  Ramachandran 
analysis carried out by MolProbity [144,145] shows that 99.1% of the residues are in 
preferred regions and the remaining 0.9% of the residues are in allowed regions 
(Table 3.1). 
Structural analysis of HopBA1. 
The structure of HopBA1 includes residues 23-239, and lacks only the N-
terminal portion used for delivery by the TTSS.  HopBA1 has an α/β fold consisting 
of a parallel β core (Figure 3.2A).  Sequentially the secondary structural elements 
are as follows: α1-β1-α2-β2-α3-5-β3-α6-β4-α7-β5-6 (Figure 3.2B).  There are four ions 
modeled with the structure of HopBA1, 3 chlorides ions (Cl-) and a potassium ion 
(K+) (Figure 3.2A).  The chloride ions do not hydrogen bond with HopBA1.  In 
contrast, the potassium ion hydrogen bonds with carbonyls from the peptide 
backbone of residues D200, P202, and M205 (Figure 3.3).  The electron density and 
hydrogen bond distances (Table 3.2) are also consistent with an iron ion (Fe2+) in 
place of the potassium ion, however, the additional positive charge of the iron atom 
would not be electrostatically compensated in the model and iron was therefore 
rejected.  Subsequent experimental analyses, e.g., rubidium ion substitution 
[146,147], would be needed to define definitively the nature of this ion.  At this time 
we cannot infer biological relevance for any of the ions associated with the crystal 
structure.   
Additionally, a compound of unknown structure is being held in a cleft of 
HopBA1 formed by portions of the α2/β2 loop, as well as, α6 and α7 (Figure 3.2); it 
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is coordinated by hydrogen bonds with H56, R162, and H193 (Figure 3.4).  To the 
best of our knowledge this compound does not correlate to anything present in the 
purification buffers, the crystallization conditions, or any degradation product of 
these components. 
Functional analysis of HopBA1. 
It was impossible to produce a homology model of the structure of HopBA1 
since multiple sequence alignments could not identify appropriate structural targets.  
However, once the structure of HopBA1 was determined, we used it to search the 
Protein Data Bank for structural homologs using the DALI server.  This search 
indicated that HopBA1 is structurally related to the EreA-like/ChaN superfamily of 
proteins sharing a similar α/β fold with all β-strand core as defined by SCOP [148].  
This superfamily (Figure 3.5) currently consists of: i) ChaN from Campylobacter 
jejuni [2], ii) the EreA-like succinoglycan biosynthesis protein Bcr136 from Bacillus 
cereus [3], and iii) a portion of the C2 domain of Pasteurella multocida 
dermonecrotic toxin (PMT) [149].  Interestingly, excluding its type three secretion 
signal that is disordered in the crystal structure, HopBA1 represents a minimal fold 
present in all family members (Figure 3.5).  ChaN and Bcr136 have insertions of 
variable length and composition between β3 and α6 of the canonical fold (Figure 
3.2B) while PMT loses the terminal β6 strand and instead has “sandwiched” the 
canonical fold between two other functional domains [149] (Figure 3.5).  
 Of these three proteins, ChaN is the best understood.  It is a lipo-protein 
associated with the membrane receptor ChaR and is used to bind and transport 
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heme from infected host cells into pathogenic Campylobacter sps.  Heme 
coordination by ChaN is atypical in that the heme is sandwiched between Y148ChaN 
of one monomer of ChaN and H176ChaN and K196ChaN of a second monomer.  This 
constellation of residues is not conserved within the sequence of HopBA1.  Indeed, 
both Y148 and H176 are within the varible β3/α6 region (Figure 3.5; grey) of ChaN.  
Nevertheless, superposition of ChaN and HopBA1 structures suggest the potential 
preservation of a heme binding pocket within HopBA1.  For example, Y158 of 
HopBA1 spatially coincides with Y148 of ChaN and may serve a similar purpose in 
heme coordination (Figure 3.6).  This possibility is especially intriguing in light of the 
fact that pathogens have evolved mechanisms to sequester heme from their hosts to 
enhanced pathogenesis [150,151].  Heme is also involved in the production of 
reactive oxygen species (ROS), MAMP-triggered immunity and pathogen-induced 
host leaf chlorosis [152]. Therefore, the potential of HopBA1 to bind heme was 
tested (Figure 3.7).   
HopBA1 does not appear to bind heme. 
Isolated heme maximally absorbs light in the near UV wavelengths (370- 
400nm).  However, when heme is bound to a protein, a Soret band is induced [153].  
In the absorbance spectra for heme upon addition of ChaN, a Soret band at 402.9 
nm with a shoulder at ~370nm and Q1 and Q0 bands appear at 508.3 and 533nm 
respectively [2].  We decided to replicate this assay for heme binding with purified 
wild type HopBA1 in comparison to a known heme binding protein, hemopexin 
(HPX; [154]).  Addition of HPX to heme generated a Soret band (414nm maximum) 
as well as additional spectral shifts (524nm; Q1 and 560nm; Q0) (Figure 3.7).   
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The addition of HopBA1 to heme does not generate a Soret band (Figure 
3.7).  This result strongly suggests that HopBA1 does not bind heme and therefore 
lacks the functionally equivalent residues used by ChaN to bind heme. Alternatively, 
HopBA1 may bind a related tetrapyrrole required for the biosynthesis of heme and 
chlorophyll [155]. Consequently, uroporphyrinogen III and protoporphyrin IX were 
also tested, but did not to bind HopBA1 (data not shown).  
Structurally-informed site-directed mutagenesis of HopBA1. 
Although HopBA1 does not bind heme or related tetrapyrroles, it does 
possess a hydrophobic patch analogous to the surface used by ChaN to bind heme.  
To further probe potential functions of HopBA1, this hydrophobic patch and 
surrounding residues were subjected to mutational analysis (Figure 3.8).  Fourteen 
residues were individually mutated to alanine and the resulting HopBA1 mutants 
were assayed for their ability to trigger HR in Arabidopsis thaliana (accession Ag-0).  
For these experiments, we generated strains of Pseudomonas fluorescens (Pfo-1), 
an ‘effector free’ genome, engineered to carry a type III secretion system and 
demonstrated to deliver single TTSS effectors [108]. 
Individual substitution of most of the peripheral residues did not diminish the 
capacity of HopBA1 to elicit HR (Figure 3.8B; grey side chains in Figure 3.8A). In 
contrast, many of the centrally located, hydrophobic residues were required to elicit 
HR (Figure 8B, colored side chains in Figure 3.8A). These included Y158, the 
residue positioned similarly to the major heme-coordinating Y148 of ChaN. However, 
individual substitutions at three of these sites (Figure 3.8A; red) produced HopBA1 
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mutants that failed to translocate through the TTSS (Figure 3.8C) when fused to 
Δ79AvrRpt2 [116]. These mutations likely affect the overall structure and stability of 
HopBA1 inside the bacterium such that it fails to load onto the type three secretion 
apparatus. Two of the remaining five HopBA1 mutants showed a partial 
translocation defect (Figure 3.8C; orange side chains in Figure 3.8A) while the 
remaining mutants were fully competent for translocation (Figure 3.8C; green side 
chains). Wild type HopBA1 and all mutants accumulated to similar levels in P. 
fluorescens (Figure 3.8D). 
 Given that all mutant forms of HopBA1 accumulate to similar levels, yet 
exhibit a spectrum of translocation potential, it seems likely that poorly translocated 
mutants are also thermally unstable. This idea was tested for a representative set of 
purified HopBA1 mutant proteins using differential scanning fluorescence (Figure 
3.9) [156,157]. Indeed, mutant forms of HopBA1 that are at least partially capable of 
translocation (i.e., H56A or Y158A) possess essentially wild type stability. In contrast 
HopBA1 (E83A) fails to translocate and is relatively unstable. 
HopBA1 lacks esterase activity found in structural homologs. 
In order to gain further insight into the function of HopBA1, residues identified 
in the mutational analysis as being required to elicit HR were mapped onto its 
surface and compared to residues required for heme scavenging by ChaN and 
esterase activity by Bcr136 (Figure 3.10) [2,3].  The functional patches of HopBA1 
and ChaN do not overlap.  In contrast, the functional residues of HopBA1 and 
Bcr136 share considerable spatial overlap. 
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Bcr136 is inferred to function during succinoglycan biosynthesis [158]; 
however, this assumption has not been experimentally confirmed. Recently, Bcr136 
was used as a structural template for the erythromycin esterases, EreA and EreB 
from E. coli [3]. As part of these studies, Bcr136 was tested for esterase activity; it 
lacked the ability to hydrolyze erythromycin [3].  However, Brc136 was able to cleave 
the simple ester p-nitrophenyl butyrate.  EreA, EreB and related esterases use a pair 
of glutamates (E81Bcr136, E112Bcr136) and a pair of histidines (H84Bcr136, H309Bcr136) 
for catalytic activity.  Single point mutations of these residues in EreBE. coli resulted in 
either significant decrease or total loss of activity.  Intriguingly, the authors also 
noted that ChaN maintains conservation of this catalytic motif (Table 5) [3].  
Furthermore, while PMT lacks this catalytic motif, it is strongly conserved in HopBA1 
(D54-H56-E83-H193).  Unfortunately, neither wild type nor mutant forms of HopBA1 
possessed esterase activity using the assay described by Morar et al. [3]. We 
conclude that HopBA1 has a novel, undetermined function that helps it subvert plant 
immunity and that is likely unrelated to heme sequestration or esterase activity. 
The C2 domain of PMT has no annotated function and thus cannot be used to 
extrapolate function for HopBA1.  In order to extend our analysis of HopBA1, γ-
proteobacterial genomes were queried for sequences that showed structural 
homology to ChaN, Bcr126, and PMT.  Two additional TTSS effectors, HopB1 and 
HopAC1[25,159], were predicted to have structural homology to the PMT C2 
domain.  HopB1 has a single domain (residues 236-449) predicted to be structurally 
homologous to the portion of the PMT C2 domain that is similar to HopBA1 (Figure 
3.11). HopAC1 has two predicted structurally homologous regions; one corresponds 
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to the entire PMT C2 domain (residues 1169-1552; Figure 3.12) and a second 
smaller C-terminal region (1729-1915) that corresponds to the minimal fold of 
HopBA1 (Figures 3.11). Without determining the crystal structure of both HopB1 and 
HopAC1, the potential modulation of function contributed by other domains cannot 
be inferred. 
  
Discussion 
Cumulatively, these data suggest two hypotheses regarding the origin of the 
EreA-like/ChaN superfamily fold.  The first is that HopBA1 represents a core fold that 
is most representative of the ancestral protein.  As the ancestral protein evolved, 
insertions occurred between β3 and α6 that led to altered function in ChaN and 
Brc136.  During the independent evolution of PMT, β6 was lost and the remainder of 
the minimal fold was fused between two other functional domains.  Alternatively, 
another superfamily member most closely resembles the ancestral protein and 
HopBA1 has undergone a series of deletions to alter the ancestral fold.   The 
observation that non-functional members arise from functional members of enzyme 
families supports the latter hypothesis [160].  However, one caveat is that this data 
set is skewed by the structures present in the PDB; i.e., the deposition of functional 
proteins far outweigh that of their non-functional homologs.  To accurately annotate 
the EreA-like/ChaN superfamily, functional determinations for all of the members, 
including HopBA1, the C2 domain of PMT, and the newly identified HopB1 must 
occur.  While the legitimacy of HopAC1 as an actual translocated effector has been 
called into question [161], it may also prove interesting to study these subdomains. 
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As more information becomes available, the number of protein folds found in 
nature is not as vast as what was once believed. Some reports put the final number 
at 1000 [162].  The blueprint of every protein is its fold and this fold defines the 
orientation of the catalytic residues, interaction surfaces, and accessibility to ligands. 
Bashton and Chothia [163] found that the amino acid identity of homologous pairs of 
domains ranged from 1-42% with most values in the lower range.  As proteins 
evolve, their functions can and often do extensively diverge.  Functionally diverse 
enzyme superfamilies maintain conservation of the active sites responsible for 
catalysis but individual members evolve to catalyze many different reactions [163]. 
Changes in overall specificity are accomplished by incremental modifications in the 
form of insertions, deletions, and permutations of secondary structure that modify 
the placement of the catalytic residues [164].  Organization of secondary structure 
can vary greatly between distant homologs due to the acquisition of new structural 
elements allowing for the homologous proteins to change in both shape and size 
throughout the course of evolution [162].  Also affecting global protein structure are 
gene duplications and fusions that have the ability of adding additional domains to 
proteins, thereby altering their specificity or function [164]. Gerlt and Babbitt 
commented that because of the aforementioned properties of homologous proteins, 
a combinatorial approach of “explicit” structure mapping of conserved structural and 
functional elements will unveil the tenants of evolution in enzyme superfamilies 
[165]. 
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Figure 3.1. HopBA1 forms crystals large enough for diffraction analysis in slightly 
different conditions.  (A) Initial positive hit from hanging drop vapor diffusion crystal 
screen (B) Crystals of approximately 100µm in length are grown in 0.5M K2SO4, 0.1M 
HEPES pH 7.0 and 30% v/v PEG 400 (C) or 0.5M Li2SO4, 0.1M Tris pH 7.0 and 30% v/v 
PEG 400 (D) Seleno-methionine derivative of HopBA1 grown in same conditions as (B).	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Data Collection Refinement 
Protein HopBA1 Resolution (Å) 32.13-2.01 (2.14-2.01) 
Wavelength (Å) 0.9794 No. reflections 16,014 / 800 (2,474 / 122) 
Space Group P31 2 1 Rwork/Rfree 
19.94 / 24.03 (26.71 / 
30.56) 
Cell Dimensions 
 
No. of atoms (non-
hydrogen)   
a, b, c (Å) 64.9, 64.9, 96.4 all 1676 
α, β, γ (°) 90.00, 90.00, 120.00 protein 1635 
Resolution (Å) 32.13-2.01 (2.03-2.01) ions 3Cl-, 1K+ 
Rmerge 5.4 (100.0) water 37 
I/σI 49.9 (1.9) B factors (Å2)   
Unique reflections 16,048 (423) all 62.18 
Completeness (%) 99.9 (100.00) protein 62.38 
Redundancy 9.0 (9.1) ions 73.6 
Wilson B-factor (Å2) 43.8 water 52.32 
  
 
R.m.s. deviations   
  
 
Bond lengths (Å) 0.011 
  
 
Bond angles (°) 1.19 
  
 
Ramachandran   
  
 
favored (%) 99.1 
  
 
generally allowed 
(%) 0.9 
  
 
disallowed (%) 0 
  
 
Missing residues 1-22 
In ( ) are the statistics for the highest resolution 
shell     	   	  
	  	   	  
Table 3.1. Refinement statistics for HopBA1.	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Figure 3.2.  HopBA1 is an α /β  protein with a β  core. (A) Model of the structure of 
HopBA1; α-helices (blue), β-strands (pink), inferred chloride ions (Cl-; green) and a 
potassium ion (K+; yellow).  (B) Cartoon showing the linkage between the secondary 
structural elements.	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Element 
# structures in 
PDB 
# distances in 
PDB Min Å Max Å 
Mean 
Å 
Sr 164 250 2.33 3.77 2.75 
Ni 120 144 1.73 3.79 2.77 
Pd 1 2 2.46 3.12 2.79 
Fe 512 552 1.66 3.79 2.82 
K 1394 3840 2.04 3.8 2.85 
Zn 736 1069 1.56 3.8 2.86 
Pb 14 22 1.82 3.7 2.9 
Yb 7 7 2.37 3.71 2.91 	  
	   	  
Figure 3.3. HopBA1 crystal structure contains an inferred potassium ion held by 
carbonyl groups. Model of HopBA1 with calculated electron density map showing 
inferred potassium ion (K+) and relative distances to coordinating carbonyls of the peptide 
backbone (dashes). The 2Fo-Fc map has been contoured to 1σ.	  
Table 3.2. Coordinated metals present in structures deposited in the PDB and their 
distances (Å) from the coordinating residues.	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Figure 3.4.  HopBA1 binds an unknown compound in its central cleft. Model of the 
structure of HopBA1 showing positive electron density for an unknown compound (green 
mesh; coordinating residues, red) present in the central cleft.	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Figure 3.5 (previous page). EreA/ChaN superfamily members contain regions that 
are variable compared to the core fold represented by HopBA1.  The crystal 
structures of ChaN (2G5G), EreA-like succinoglycan biosynthesis protein Bcr136 (2QGM) 
and the C2 domain of PMT (2EBF) colored to highlighted secondary structure conserved 
in comparison to HopBA1: α-helices (blue), β-strands (pink).  Non-conserved regions are 
grey.  The C2 domain is also shown within the context of PMT (lower left).	  
Figure 3.6. HopBA1 shows structural homology to the heme scavenger protein 
ChaN from the pathogen Campylobater jejuni.  Structural alignment of HopBA1 
(blue/pink) and ChaN (silver; 2G5G).  Heme coordinating Y148ChaN (light orange) and the 
potentially analogous residue Y158 (orange) in HopBA1 are highlighted; heme moiety 
from ChaN crystal structure shown in green. Superposition (RMSD 3.34 Å) generated 
using PyMol [4] and a structural alignment produced by DALI.	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Figure 3.7. HopBA1 induces only a modest shift in heme absorption and thus does 
not appear to bind heme.  Heme spectral absorption was measured alone (green) and 
in combination with HopBA1 (blue) or HPX (red).	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Figure 3.8 (previous page).  HopBA1 mutated within its hydrophobic cleft no longer 
elicits HR in Ag-0.  (A) Fourteen missense mutations mapped onto the structure of 
HopBA1. Substitution of green side chains did not affect translocation of HopBA1 but 
prevented its recognition by Ag-0; substitution of orange and red residues produced a 
partial and full translocation defect, respectively.  Substituted residues having no effect 
on phenotype are grey. (B) Individual leaves depicting HR in Ag-0 as a function of 
representative HopBA1 mutants. (C) Assay for the ability of representative HopBA1 
mutants fused to Δ79AvrRpt2 to translocate through the TTSS. (D) Immunoblots of wild 
type and mutant HopBA1.	  
Figure 3.9. HopBA1 mutants that are translocation competent are also thermal 
stable. (A) A representative set of HopBA1 mutants purified to homogeneity and color 
coded based on translocation competence. (B) Plot of normalized fluorescence from 
thermal melt analysis of wild type and mutant forms of HopBA1. GST also tested as a 
control.	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Protein Residue 
HopBA1 D54 H56 E83 H193 
ChaN E46 H48 E80 H220 
Bcr136 E81 H84 E112 H309 
PMT N916 S918 S942 L1045 	   	  	  	  	  	   	  
Figure 3.10. Functional patches of HopBA1 and Bcr136 share considerable spatial 
overlap.  Space filling models of HopBA1, ChaN (2G5G) and Bcr136 (2QGM), are 
colored to highlighted secondary structure conserved in comparison to HopBA1: α-
helices (blue), β-strands (pink). Functional patches from HopBA1 for loss of recognition in 
Ag-0 (Figure 3.8), ChaN for heme scavenging [2], and Bcr136 for esterase activity [3] 
have been highlighted (yellow).	  
Table 3.3: The catalytic tetrad from Bcr136 is conserved among other EreA-
like/ChaN superfamily members and HopBA1.	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Figure 3.11.  Two additional TTSS effectors HopB1 and HopAC1 are predicted to 
share structural homology with the PMT C2 domain. Homology models using the 
portion of the C2 domain of PMT that is structurally related to HopBA1 as a template are 
colored according to secondary structure: α-helices (purple), β-strands (pink).	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Figure 3.12. The N-terminal fold of HopAC1 is predicted to be structurally 
homologous to the entire C2 domain of PMT. Structural alignment of HopAC1 (1169-
1552) (purple/pink) and the C2 domain of PMT (silver; 2EBF).	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CHAPTER FOUR 
Contributions to other works 
Introduction 
 The following chapter includes my contributions to other publications.  The 
publication overview of each paper is included followed by a brief description of my 
contribution. 
 
Dynamic Evolution of Pathogenicity Revealed by Sequencing and 
Comparative Genomics of 19 Pseudomonas syringae Isolates 1 
 
Closely related pathogens may differ dramatically in host range, but the 
molecular, genetic, and evolutionary basis for these differences remains unclear. In 
many Gram-negative bacteria, including the phytopathogen Pseudomonas syringae, 
type III effectors (TTEs) are essential for pathogenicity, instrumental in structuring 
host range, and exhibit wide diversity between strains. To capture the dynamic 
nature of virulence gene repertoires across P. syringae, we screened 11 diverse 
strains for novel TTE families and coupled this nearly saturating screen with the 
sequencing and assembly of 14 phylogenetically diverse isolates from a broad 
collection of diseased host plants. TTE repertoires vary dramatically in size and 
content across all P. syringae clades; surprisingly few TTEs are conserved and 
present in all strains. Those that are likely provide basal requirements for 
pathogenicity. We demonstrate that functional divergence within one conserved 
locus hopM1, leads to dramatic differences in pathogenicity, and we demonstrate 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  25.	  Baltrus	  DA,	  Nishimura	  MT,	  Romanchuk	  A,	  Chang	  JH,	  Mukhtar	  MS,	  et	  al.	  (2011)	  Dynamic	  evolution	  of	  pathogenicity	  revealed	  by	  sequencing	  and	  comparative	  genomics	  of	  19	  Pseudomonas	  syringae	  isolates.	  PLoS	  Pathog	  7:	  e1002132.	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that phylogenetics-informed mutagenesis can be used to identify functionally critical 
residues of TTEs. The dynamism of the TTE repertoire is mirrored by diversity in 
pathways affecting the synthesis of secreted phytotoxins, highlighting the likely role 
of both types of virulence factors in determination of host range. We used these 14 
draft genome sequences, plus five additional genome sequences previously 
reported, to identify the core genome for P. syringae and we compared this core to 
that of two closely related nonpathogenic pseudomonad species. These data 
revealed the recent acquisition of a 1 Mb megaplasmid by a sub-clade of cucumber 
pathogens. This megaplasmid encodes a type IV secretion system and a diverse set 
of unknown proteins, which dramatically increases both the genomic content of 
these strains and the pan-genome of the species. 
 
My contribution to this publication: 
I contributed to this publication by creating the homology models of AvrPto in 
Figure S16 panels C-F.  These models allowed us to generate hypotheses for the 
differences observed in both function and recognition of the natural variants of the 
AvrPto allele based on the biochemical properties and predicted alteration of 
structural contacts. 
 
Specific Threonine Phosphorylation of a Host Target by Two Unrelated Type III 
Effectors Activates a Host Innate Immune Receptor in Plants 2 
 
The Arabidopsis NB-LRR immune receptor RPM1 recognizes the 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2	  81.	  Chung	  EH,	  da	  Cunha	  L,	  Wu	  AJ,	  Gao	  Z,	  Cherkis	  K,	  et	  al.	  (2011)	  Specific	  threonine	  phosphorylation	  of	  a	  host	  target	  by	  two	  unrelated	  type	  III	  effectors	  activates	  a	  host	  innate	  immune	  receptor	  in	  plants.	  Cell	  Host	  Microbe	  9:	  125-­‐136.	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Pseudomonas syringae type III effectors AvrB or AvrRpm1 to mount an immune 
response.  Although neither effector is itself a kinase, AvrRpm1 and AvrB are known 
to target Arabidopsis RIN4, a negative regulator of basal plant defense, for 
phosphorylation. We show that RIN4 phosphorylation activates RPM1. RIN4142-176 is 
necessary and, with appropriate localization sequences, sufficient to support 
effector-triggered RPM1 activation, with the threonine residue at position 166 being 
critical. Phosphomimic substitutions at T166 cause effector-independent RPM1 
activation. RIN4 T166 is phosphorylated in vivo in the presence of AvrB or AvrRpm1. 
RIN4 mutants that lose interaction with AvrB cannot be coimmunoprecipitated with 
RPM1. This defines a common interaction platform required for RPM1 activation by 
phosphorylated RIN4 in response to pathogenic effectors. Conservation of an 
analogous threonine across all RIN4-like proteins suggests a key function for this 
residue beyond the regulation of RPM1. 
 
My contribution to this publication: 
I generated the rendering of the co-crystal structure of the RIN4 peptide and 
AvrB, illustrating residues critical for interaction between the two proteins. I also 
created several additional models illustrating the missense mutations of RIN4 (not 
shown).  These models allowed for speculation on the interaction of the mutated 
residues on RIN4 with the binging pocket of AvrB and how mutation might lead to 
loss of interaction.  
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Expanded functions for a family of plant intracellular immune receptors 
beyond specific recognition of pathogen effectors 3 
 
 Plants and animals deploy intracellular immune receptors that perceive 
specific pathogen effector proteins and microbial products delivered into the host 
cell. We demonstrate that the ADR1 family of Arabidopsis nucleotide-binding 
leucine-rich repeat (NBLRR) receptors regulates accumulation of the defense 
hormone salicylic acid during three different types of immune response: (i) ADRs are 
required as “helper NB-LRRs” to transduce signals downstream of specific NB-LRR 
receptor activation during effector-triggered immunity; (ii) ADRs are required for 
basal defense against virulent pathogens; and (iii) ADRs regulate microbial-
associated molecular pattern-dependent salicylic acid accumulation induced by 
infection with a disarmed pathogen. Remarkably, these functions do not require an 
intact P-loop motif for at least one ADR1 family member. Our results suggest that 
some NB-LRR proteins can serve additional functions beyond canonical, P-loop–
dependent activation by specific virulence effectors, extending analogies between 
intracellular innate immune receptor function from plants and animals. 
 
My contribution to this publication: 
 I created the homology model for the CC-NB domain of ADR1-L2 using the 
known structure of Apaf1 in Figure S7 panel A and B.  This model confirmed the 
spatial conservation of an intact P-loop in ADR1-L2 despite its dispensability for the 
protein functions assayed. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  166.	  Bonardi	  V,	  Tang	  S,	  Stallmann	  A,	  Roberts	  M,	  Cherkis	  K,	  et	  al.	  (2011)	  Expanded	  functions	  for	  a	  family	  of	  plant	  intracellular	  immune	  receptors	  beyond	  specific	  recognition	  of	  pathogen	  effectors.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  108:	  16463-­‐16468.	  
 91 
 
A new eye on NLR proteins: focused on clarity or diffused by complexity? 4 
The nucleotide-binding domain leucine-rich repeat proteins (NLRs) represent 
the major class of intracellular innate immune receptors in plants and animals. 
Understanding their functions is a major challenge in immunology. This review 
highlights recent efforts toward elucidating NLR functions in human and plants. We 
compare unconventional aspects of NLR proteins across the two kingdoms. We 
review recent advances describing P-loop independent activation, nuclear-
cytoplasmic trafficking, oligomerization and multimerization requirements for 
signaling, and for expanded functions beyond pathogen recognition by several NLR 
proteins. 
 
My contribution to this publication: 
I computationally scanned all proteins previously classified as / or with a high 
degree of similarity to NB-LRRs from Arabidopsis thaliana and Arabidopsis lyrata 
using the motif search algorithm MEME.  This led to the identification of several 
classes of proteins containing unconventional P-loop motifs and the hypothesis that 
these proteins may function as immune signaling scaffolds.  This data set was 
compiled into Table 1. 
 
 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4	  167.	  Bonardi	  V,	  Cherkis	  K,	  Nishimura	  MT,	  Dangl	  JL	  (2012)	  A	  new	  eye	  on	  NLR	  proteins:	  focused	  on	  clarity	  or	  diffused	  by	  complexity?	  Curr	  Opin	  Immunol	  24:	  41-­‐50.	  
CHAPTER FIVE 
Conclusions and future directions 
Introduction 
 Hidden at the primary sequence level, type three secretion system effectors 
can display structural homology to host proteins with determined functions [168].  
This shared structure/function relationship allows the bacterial effector to subvert 
biological mechanisms within the host [99].  Direct molecular mimicry of host 
processes allows for discrete function inside the host and minimal disruption to the 
host environment allowing for both desired virulence effects and minimal perception 
by the host [55,59,99,169,170]. 
 
Discussion 
The work described in this dissertation concentrates on elucidating the 
function of two type three secretion system effectors, AvrRpm1 and HopBA1 using 
insights gained from computational and crystallographic structural analysis, 
respectively.  Both proteins were previously identified as elicitors of disease 
symptoms on resistant plants [5] (data to be published for HopBA1). 
 Computational homology modeling shows that AvrRpm1 adopts the fold of 
the catalytic domain of poly(ADP-ribosyl) polymerase including a putative catalytic 
triad of H63-Y122-D185 (Chapter 2 Figure 1).  Although we were unable to directly 
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attribute ribosylation activity to AvrRpm1 (Chapter 2 Figure 2.9), we show that an 
intact catalytic triad is necessary for recognition of AvrRpm1 by its cognate 
resistance protein RPM1 (Chapter 2 Figure 2.3A).  Additionally, a missense mutation 
of D185 to alanine leads to recognition by an additional R protein RPS2, that is not 
primarily associated with AvrRpm1 mediated defense responses in disease 
susceptible hosts (Chapter 2 Figure 2.5 A and B).  Direct RPS2 activation should be 
confirmed by replicating the growth curve assay from Chapter 2 Figure 2.6 using 
Arabidopsis lacking RPS2 (i.e. rps2).   This recognition is ameliorated in the double 
AvrRpm1 missense mutation G2A D185A that is compromised for proper localization 
to the plasma membrane [6].  Additionally, we show that the suppression of bacterial 
growth due to RPS2 mediated recognition of the D185A missense mutation may not 
be dependent on the presence of RIN4 (Chapter 2 Figure 2.5C) and neither 
AvrRpm1 nor any of the missense mutants derived from it compete for RIN4 in an 
appreciable manner in the presence of AvrRpt2 (Chapter 2 Figure 2.8).  An 
interesting experiment to consider is mutating D185 of AvrRpm1 to a glutamate (E) 
in order to create a mutant carrying the canonical catalytic triad (Chapter 2 Figure 
2.1) and test for its ability to alter the ribosylation profile. 
 While the homology model for AvrRpm1 provided us with enough insight to 
generate workable hypotheses, it only covered roughly 60% of the total length of 
AvrRpm1.  The regions excluded from the model include the type three secretion 
signal and the large inferred loops interspersed in the predicted β-core of the protein. 
According to Otto et al., these loops are predicted to be sites of substrate interface 
[68].  Without a true crystal structure we will never know exactly how these loops fold 
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or if there are regions of discrete secondary structure within them. This is similar to 
the crystal structure of HopF1 that showed additional structural elements occlude the 
putative active site cleft, despite showing overall structural homology with the ADP-
ribosyl transferase Diphtheria toxin [74]. 
 All of our attempts at achieving a soluble, homogenous AvrRpm1 protein after 
purification were unsuccessful (Chapter 2 Figure 2.10), which could be due to a lack 
of host specific post-translational modification or an unknown target/binding partner 
necessary for proper AvrRpm1 folding once inside the host.  The notion that 
AvrRpm1 is intrinsically disordered is intriguing given the fact that disordered 
proteins function in highly diverse manners within the host, often adopting specific 
conformations depending upon the environment or binding partner present [171].  
Given the observation many TTSS effectors exhibit regions of predicted disorder, 
this may be an inherent mechanism for spatiotemporal regulation of effector 
function, i.e. the effectors fold and thus function when new targets and folding 
partners are presented as the host responds to various pathogenic stimuli.   
 In order to test this hypothesis, progress needs to be made in AvrRpm1 target 
identification. To overcome this, utilization of protein overexpression systems from 
Nicotiana benthamiana [172] or tandem expression of AvrRpm1 with NOI domain 
containing proteins could lead to purification of a properly folded protein and 
simultaneousl target identification. Protein purification from N. benthamiana is 
especially attractive for AvrRpm1, given that the immune perception pathway can be 
reconstructed in N. benthamiana providing any required post translational 
modifications or unknown folding partners [81,172]. 
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 Despite our difficulties with AvrRpm1, we were able to determine the crystal 
structure for the novel the TTSS effector HopBA1 (Chapter 3, Figure 2A) [25].  We 
found that HopBA1 had a β-strand core populated by hydrophobic residues and that 
mutation of several of these residues led to a loss of recognition within a disease 
resistant host (Chapter 3 Figure 6A and B).  We observed that HopBA1 shares 
structural homology with the heme binding protein ChaN from Campylobacter jejuni, 
a putative esterase Bcr136 from Bacillus cereus, and the C2 domain (function 
unknown) of PMT from Pasteurella multocida (Chapter 3 Figure 5 and 9) [2,3,149].  
We extended the homology from this superfamily to two additional P. syringae TTSS 
effectors, HopB1 and HopAC1 (Chapter 3 Figure 13 and 14).  However, we are 
unable to assign an enzymatic function to HopBA1 despite its shared homology to 
these other proteins (Chapter 3 Figure 8 and data not shown).  A key to revealing 
the activity of HopBA1 may reside in identification of the unknown compound located 
within the β-cleft (Chapter 3 Figure 4).  Additionally, identification of host targets of 
HopBA1 as well as the protein(s) responsible for recognition of HopBA1 will provide 
insight into the molecular function of this protein.  Identification of the targets and 
resistance proteins of HopBA1 is currently being performed by Marc T. Nishimura 
and will be presented with the crystal structure as a collaborative publication. 
 The collective successes from the “medium-high throughput” proteomics 
pipeline presented in this dissertation have lead to the creation of a proteomics 
database for archetype family members of most of the known TTSS effector families.  
This database includes basic physiochemical information on each protein, predicted 
structures (where they could be reliably ascertained), as well as initial cloning 
 96 
constructs to further streamline our initiatives.  Preliminary progress has been made 
in small scale protein production for a few of the TTSS effectors tested (Marc 
Nishimura and Michael Huynh).  It is our anticipation that this pipeline will provide 
valuable insight into the molecular mechanisms of disease, especially given the lack 
of sequence conservation and redundant functionality observed with TTSS effectors. 
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